PURPOSE: As one working group of the NPUAP "Support Surface Standards Initiative," members of the "Terms and Definitions" group initiated a process to develop standardized terms and definitions to ensure global consistency with support surface device nomenclature. OBJECTIVE: Group participants began by developing a list of terms related to support surface devices. These terms were grouped according to product categories. After listing definitions reported in journal articles, government publications, pressure ulcer guidelines, and industry marketing material were complied in a categorical listing. The definitions were reviewed and discussed, after which the group developed and agreed on revised, new, changed, combined, or deleted definitions. OUT-COMES: During the first meeting in January 2002, the group members determined individual terms and definitions that needed to be reviewed. Current terms were developed as either physical or engineering based or were developed or evolved by the support surface industry. The group was cautious to ensure that the purpose of the project and proposed terms and definitions was to develop a common language regarding support surface design and technology that could be clearly understood by clinicians, engineers, and the support surface industry. Support surface terminology, such as low air loss, alternating air pressure support surfaces, air-fluidized therapy, pressure reduction, and pressure relief, were the most challenging terms for group consensus but now have definitions. Well-written, descriptive, measurable support surface terms and definitions have been developed, but the work continues. CONCLUSION: The operational process the group utilized to develop and agree on revised, new, changed, or combined terms and definitions will be reported during the oral presentation via a 4-member panel comprised of both clinicians and industry participants of the working group. This presentation may promote more WOCN clinicians to participate in the important work of this initiative. Donna Z. Bliss, PhD, RN, FAAN, bliss@umn.edu; Cindy Zehrer, MS, RN; Kay Savik, MS; Li Ding, MS; and Edwin Hedblom, PharmD, 
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AN ECONOMIC EVALUATION OF SKIN DAMAGE PREVENTION REGIMENS AMONG NURSING HOME RESIDENTS WITH INCONTINENCE: LABOR COSTS
University of Minnesota School of Nursing, Minneapolis
PURPOSE: Reports of high rates of incontinence in nursing home (NH) residents suggest prevention of incontinence dermatitis (ID) is a major nursing concern. Little is known about the cost of ID prevention. The purpose of this study was to examine cost and efficacy of 4 ID-prevention regimens in NH residents. Staff labor costs of the regimens are reported. METHODS: Residents (n = 1,918) in 16 US NHs, randomly selected, were screened for eligibility; 981 residents qualified and were enrolled. All were incontinent and started free of perineal skin damage. Age and sex did not differ among the groups (P > .05). The regimens included use of a barrier film applied 3 times weekly (A) and 3 ointment barriers of different composition applied after each incontinence episode (B, C, and D) . Measures of caregiver labor (number and time) for ID prevention on 888 qualified residents (712 F, 176 M; age <90 years = 72%, ≥90 years = 28%) were used in the economic analysis. Staff assessed resident skin damage for 6 weeks to determine efficacy of the regimens. RESULTS: Overall occurrence of skin damage was 4.6%, of which 74% was attributed to ID; neither incidence differed significantly among the groups (P = .07 for both). The median number of incontinence episodes/day differed among the groups (A = 6.2, B = 6.3, C = 7.0, D = 6.7; P = .005). Different numbers of staff provided ID prevention care (range = 1 to 4; P < .001). Due to these differences, the analysis standardized the cost of staff labor per 100 episodes of incontinence provided per one caregiver. The median labor cost of regimen A ($19.68) was significantly less than B ($55.60), C ($25.40) , and D ($40.20; P <.001). Median labor cost of applying barrier A ($.70) was less than B ($12.00), C ($8.00), and D ($13.00; p < .001). CONCLU-SION: Use of a skin barrier film applied 3 times weekly is effective in preventing ID and saves significant staff labor costs. OBJECTIVE: The purpose was to describe long-term adjustment in persons with a continent ileostomy. SUBJECTS AND METHODS: Sixty eight persons (25 males/43 females) operated on for ulcerative colitis with a continent ileostomy (Kock pouch) had median of 31 years' (range 29-36) experience of living with a continent reservoir and had a median age of 60 (40-89) at follow-up. The persons completed a 36-item questionnaire designed to assess adjustment to ostomy surgery. Ratings were made on a 6-point Likert scale, with a response alternative "not relevant" available. A content analysis was conducted on responses to an open-ended question covering aspects of the patients' quality of life (QoL). RE-SULTS: High median adjustment ratings were found for all 36 statements and the maximum median rating of six appeared on 28 items. Eight items with the lowest median ratings were found in the following domains: embarrassing situations, activity, body image, sexuality, and good care. Five items on medical care and 3 items on sexuality were most frequently considered not relevant. The most frequently mentioned QoL domains were family, health, friends, and employment. Content analysis indicated that the informants were self-reliant, but they also experienced considerable impediments to bowel evacuation outside of the home. CONCLUSIONS: In the long-term, persons with a continent ileostomy have good self-care. The quality and availability of public restrooms reduce their daily activities away from home.
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TRENDS IN PRESSURE ULCER PREVALENCE: 1989-2004
Janet E. Cuddigan, PhD, RN, CWCN, CCCN, jcuddiga@unmc.edu, and Jackie Young, RN, CWCN, University of Nebraska Medical Center, Omaha, Neb PURPOSE/RATIONALE: The first national pressure ulcer prevalence survey was conducted in 1989. Over the next 15 years, surveys were routinely repeated to include 362,092 patients from multiple settings. The purpose of this abstract is to review trends and explore implications for the future. METHODOLOGY: Standard data collection forms were developed. Data collectors received uniform instructions and training. Demographic, risk factor, and skin assessment data were recorded for all patients. Although core data elements and collection strategies were constant, improvements were made to meet the evolving information needs of healthcare providers, researchers, and policy makers. In 1995, department-level results were reported to guide specific quality improvement efforts. In 1999, facility-acquired ulcers were differentiated from those present on admission. In 2003, the prevalence survey was conducted internationally. RESULTS: The number of participating facilities has grown steadily from 148 facilities in 1989 to 645 facilities in 2004. The overall prevalence has increased from 9.2% in 1989 to 15.5% in 2004. Facility-acquired rates have remained relatively steady at 7. 1% in 1999, 8.6% in 2001, 6.8% in 2003, and 7.7% in 2004 . The facility-acquired rates, excluding stage I, have remained consistent at 4.3% in 2001 , 3.5% in 2003 , and 4.1% in 2004 . In 2004 , facility-acquired rates were marginally higher in long-term acute care facilities at 8.8%, followed by 7.8% in acute care, and 6.0% in long-term care. Anatomically, 28.3% of all ulcers were on the sacrum, 24.1% on heels, 16.7% on buttocks, 6.4% on feet, 3.8% on legs, 3.6% on elbows, 3.1% on ischia, and 2.8% on trochanters. CONCLUSION: These surveys have allowed facilities to benchmark against other institutions and focus on specific quality improvement initiatives. Collectively, these results provide a unique overview of trends in pressure ulcer prevalence over the past 15 years and a basis for future planning.
care for the prevention of perioperative PU. METHODOLOGY: The study design was a single-center prospective matched control two-group comparison study. A total of 323 high-risk patients were separated into two groups. Groups were compared postoperatively for the outcome variable presence of a PU. The control group (n = 176) went through surgery on a standard OR table pad, while the study group (n = 147) utilized a multilayer pressurereduction surface. Selection criteria included age, procedure length, and absence of pressure ulcers. There was no difference between the two groups according to their key risk factors of age, albumin, and American Society of Anesthesiologist (ASA) physical status scores. Prior to surgery and for 3 days post-op a member of the research team performed skin assessments observing for PU incidence. RESULTS: Statistically significant variables include age, albumin, race, ASA scores, and the experimental pad. The multilayer surface was statistically significant (P < .000) in reducing the incidence of PU compared with the "standard" OR table. Variables that were not significant included Braden scale, comorbid conditions, smoking, and intraoperative variables, such as time on the table. CONCLUSION: Development of nosocomial PUs is a patient safety issue. These data indicate that risk assessment is unproven; therefore, evidence-based best practices are necessary when developing a program to reduce perioperative PU. As a patient advocate, the WOCN plays an important role in assessment, prevention, and staff education to promote quality outcomes.
Case Study Abstracts
Ostomy-Stomal/peristomal complications 600 PERISTOMAL PYODERMA GANGRENOSUM-A RARE CHALLENGE Kimberly R. Masters, BSN, RN, CWOCN, kmasters@bhsi.com Central Baptist Hospital, Lexington, Ky A 33-year-old female presented to her physician with a 2-day draining peristomal wound, fever, pain, decreased appetite that the physician misdiagnosed as an enterocutaneous fistula. At 5′6″ and 79 kg, she has a history of Crohn's disease and had an APR with colostomy in March 2003. Within a 2-week period, symptoms worsened and she developed a large painful draining peristomal ulceration with a granular base and a bluish ragged raised edge. Challenge to the WOC nurse was managing a draining peristomal wound and maintaining pouch wear time. Initial therapy included weekly outpatient visits to the WOC nurse with patient doing QOD dressing changes at home with sodium carboxymethylcellulose fiber dressings covered by a transparent dressing to allow for pouch adhesion and one-time dose of Depo-Medrol injected by MD. Epithelialization began in the wound bed and by week 6, visits decreased to every 2 weeks. Treatment continued with same dressings only adding it impregnated with silver. At week 11, the patient's condition worsened, PPG reopened, and patient developed a fistula requiring placement of a drain. DepoMedrol injections into wound bed continued biweekly, and the patient began receiving Remicade for return of Crohn's disease. Improvement was seen in the first 6 weeks of therapy by using dressing changes and wound injection of corticosteroid. But therapy change was needed when wound deteriorated. OBJECTIVE: Dressing changes qod with injection of corticosteroids q 2 weeks. SUBJECTIVE: Simple dressing changes and a system allowing for pouch adhesion. Topical dressings alone with one injection of a corticosteroid were not sufficient to heal the PPG. Current therapy includes topical dressing therapy with and Depo-Medrol injections. LIMITATIONS: leakage leading to 1-2 day pouching changes a day, sometimes causing irritant dermatitis. Patient has sensitivity to Stomahesive Durahesive wafers and is using karaya pouching system. The patient continues to be followed by WOC nurse and colorectal surgeon.
Professional Practice-Clinical Practice Outcomes, Standards of Care, Clinical Pathways
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USE OF A 3-D SOFT FOOT MODEL (EZ MEDICAL TEACHING FOOT) FOR A FOOT CARE PROGRAM FOR A VETERANS AFFAIR PATIENT POPULATION
Shelly R. Burdette-Taylor, MSN, RN, C, CWCN, shelly@taylordhealth.com, Taylor'D Health Education/Consultation, San Diego PURPOSE/RATIONALE: The purpose of this pilot study is to determine the effectiveness of a foot care program using a 3-dimensional soft-foot model as a teaching tool in describing basic foot care to individuals who have been identified at risk for limb loss. METHOD-OLOGY: This is a randomized 2-group study in which the sample was drawn from the VA Hospital-San Diego. The dependent variables are locus of control, knowledge, and patients' perception of effectiveness of the foot model. Each subject was screened utilizing the VA Foot Assessment and Teaching Form. A self-administered 15-item disease nonspecific locus of control was requested of each participant for assessing the individuals' perception of healthcare locus of control. An 11-item demographics questionnaire was obtained. A 15-item true/false knowledge test was given before and after interventions of foot care/foot wear education, screening, and treatment. RESULTS: Twenty-three male veterans were enrolled into the study. There were 78% Caucasian, 17% African American, and 5% Mexican American. The subjects ranged in age from 47-85 years. The majority of the subjects had lower extremity arterial disease with diabetes as the second highest incidence. Eighty percent stated had previous foot care education. There was a slightly higher score on the baseline knowledge test for the group that used the soft foot model but no true significance. CONCLU-SION: The project's clinical relationship is to support the hypothesis that a 3-dimensional soft foot model is an effective educational tool that is practical, easy to use, and nonthreatening to the patient and able to be manipulated for individuality in teaching/learning. These authors believe that education is an essential component of foot care behavior to prevent injuries leading to amputation. With use of a 3-D foot model, it meets the needs of visual and kinetic learners, which could promote retention of information. Susan Coppola, BS, RN, scoppola@hbrside.com, and Edwina M. O'Rourke, Harborside Healthcare, Boston Pressure ulcer prevention and management is one of the greatest challenges facing caregivers and healthcare facilities. Developing standardized protocols or clinical pathways alone is not enough. While prevention programs may provide the policies to create the desired outcomes, they rarely meet the needs of staff for structure, support, and education regarding the etiology of pressure ulcers, the maintenance of intact skin, and meeting the needs of their residents, as well as the requirements of the nursing home. The relationship between nurses' perceptions of workplace empowerment and nurses' knowledge of pressure ulcers on patient care outcomes among long-term care facilities was examined by Regan (2002) . Regan discusses theories of organizational empowerment of the individual care providers. In this model the determinants 2835-02_WJ3203-Abst-newrev.qxd 05/04/05 12:47 Page S3 S4 Abstracts J WOCN ■ May/June 2005 of personal behavior in organizations are a result of the work environment and are produced by conditions related to the operation of the organization (structure, information, support, and opportunity to succeed) rather than by the individual personality traits of the employees. The understanding of these relationships does have a positive impact on the quality of work life experienced by employees, resulting in positive personal patient care and organizational outcomes. This poster presentation will detail the success story of a facility within an organization of long termcare providers by incorporating the elements of education, support, and structure, which enable the individual to succeed. The empowerment of the facility staff in combination with an extensive education and skin care program resulted in a decrease in the incidence of pressure ulcers from 26% to only 3%. Also, the turnover of staff was dramatically reduced as well as the costs incurred from contract labor. The empowerment of the nursing director to take ownership of wound care has led to the high standard of care that is now paramount in this facility.
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IT'S MORE THAN SKIN DEEP: A SUCCESS STORY OF ORGANIZATIONAL AND INDIVIDUAL CHANGE
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DESIGNING, DEVELOPING, AND DELIVERING AN EDUCATIONAL WEB SITE: TO MARKET YOUR PASSIONS, PRODUCTS, AND PROGRAMS
Shelly R. Burdette-Taylor, MSN, RN, C, CWCN, shelly@taylordhealth.com, Taylor'D Health Education/Consultation, San Diego PURPOSE: Using the Internet to get your word out is exciting, simple, and comprehensive. It is an excellent way to incorporate innovative electronic communication to marketing yourself as well as your passions, products, and programs. Designing, developing, and delivering a Web site allows for advertising CEU programs planned and self-study opportunities, such as video, audio, CDs, and educational and wellness products for purchase. OBJECTIVE: Overcoming barriers to quality wound care is a major issue. We as a healthcare team understand more now than ever our limited resources, the need to work together as a team across settings as well as between industry, healthcare, and academia. The United States has a newer national perspective on health and wellness and the need to collaborate and communicate to prevent litigation, unnecessary costs, and negative outcomes to include life and limb loss. Electronic communication is effective and efficient. OUT-COMES: An educational Web site allows for links to other Web sites, industry products, and services that complement your passions and products. If you are an expert in a field or passionate about a specific issue in the healthcare arena that you would like to change or just promote a better understanding of, you can incorporate chat or e-mail discussions or interactive Web education. Electronic communication is a simple method of transferring ideas and information across time zones in moments. CONCLUSION: Education is powerful. It is the key to change behavior. Knowledge based on research is essential to overcome barriers in chronic wound healing. There is a trend to revitalize education, information, interest, and research. Using the Internet can only allow for greater and better dissemination of that information at ease. Stan K. McCallon, PT, CWS, stanm@lifecare-hospitals.com, and Kelly Browning, RN, CWS, Director of Physical Medicine, Director of Wound Care, Shreveport, La PROBLEM: An 88-year-old African American male admitted with pannus lesions to trunk and extremities related to bullous pemphigoid eruption. Comorbidities included CRF, HTN, and Gramnegative septicemia. PAST MEDICAL MANAGEMENT: Prior to admission, patient had been treated at referring facility with systemic corticosteroids, IV antibiotics, and a compounded topical Mupirocin/Betamethasone cream was being applied TID to the scores of partial thickness ulcerations. CURRENT CLINICAL AP-PROACH: Patient placed on diuretics to address marked edema. IV antibiotic regimen was continued and the systemic steroid was tapered to cessation over 2-week period. Topical antibiotic/steroid cream was discontinued due to concerns of potential steroid toxicity due to collective surface area represented by the pannus lesions. Balsam ointment was initially applied twice daily to all affected areas and left uncovered. The determination to use Balsam ointment was based on author's experience with use of this ointment in healing of partial thickness ulcers and information in the literature. PATIENT OUTCOMES: The use of diuretics and light compressive sleeves resolved edema. The use of Balsam ointment facilitated healing of all lesions within 21 days, at which time ointment was discontinued. Patient was able to attend therapy sessions and returned home with family following discharge. CONCLU-SION: The use of Balsam Peru, Castor Oil, and Trypsin ointment facilitated the healing of partial thickness lesions related to Bullous Pemphigoid eruption. No adverse effects were noted. The ointment maintained a moist healing environment without the need for a secondary dressing and did not leave any buildup on tissue.
Wound-Dermatological Management/Issues
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TREATMENT OF BULLOUS PEMPHIGOID LESIONS USING BALSAM PERU, CASTOR OIL, TRYPSIN OINTMENT: A CASE STUDY
605
A SOLUTION FOR PARTIAL-THICKNESS WOUNDS OF AN IMMUNE SUPPRESSED PATIENT: PLEASE DON'T "LEAVE MY WOUNDS OPEN TO AIR"
Ann Blackett, MS, RN, CWCN, COCN, CPHQ, ablackett@umcaz.edu; Patricia McDonald, ARNP-BC, CWOCN; and Susan Kay Bohnenkamp, MS, RN, CCM, University Medical Center, Tucson, Ariz STATEMENT OF CLINICAL PROBLEM: Immune suppression from cancer treatment and other complex medical conditions contribute to skin denudation. Since the wounds are on the surface, the myth of "leaving it open to air" prevails. However, the surface nerve endings need to be covered with a moist dressing. Otherwise, they communicate loudly to the brain that the skin integrity is disrupted. It is as if the nerve endings are exposed wires emitting sporadic electric charges. The patient's pain is excruciating. CASE STUDY: A 66-year-old female treated with chemotherapy for chronic lymphocytic leukemia. Her body was cover with blisters and partial-thickness wounds. The patient was without a dressing. The serous sanguineous fluid drained onto the bed linens, causing excruciating pain with the constant cycle of being stuck and unstuck to the sheets. The eventual diagnosis was Pemphigus vulgaris. INNOVATIVE CLINICAL APPROACH: This daily dressing was foaming skin care wash, nonsting skin barrier, and hydrogel sheet. Stretch and/or net bandages secured the dressings. EVALU-ATION OF OUTCOME MEASUREMENTS: Pain management via the Wong-Baker pain scale-initially the patient reported her pain level as 10 before the dressing was applied. After the dressing, pain was 1. After 12 hours, the pain advanced to 6 and 8. Another dressing change was added. Her pain remained between 1 and 2 throughout the 24 hours. Pain management via amount of pain medication-pain Medication usage decreased. Wound healing via Photographs-photographs revealed wound healing after 4 months. CONCLUSIONS: Patients with dermatologic conditions causing denudation of the skin require wound care that addresses 4 goals: (1) to prevent infection with cleansing, (2) to PROBLEM: A 91-year-old male with partial-thickness ulcers to both upper extremities related to cellulitis. History of cardiomyopathy and ESRD. PAST MEDICAL MANAGEMENT: Despite IV antibiotic therapy and topical silver sulfadiazine cream for 10 days at the referring facility, lesions were not healing. Upon admit, lesions to the right arm measured 49 cm 2 in surface area. CURRENT CLINICAL APPROACH: A decision to use a Balsam ointment was based on success on partial-thickness lesions of different etiologies, as well as information in the literature demonstrating the effectiveness of the ingredients in healing. Antibiotic therapy was continued for treatment of the underlying cellulitis. Edema control measures were in place including elevation and gentle compression with elastic sleeves. Previous topical treatment was discontinued. After cleansing, the Balsam Peru, Castor Oil, Trypsin ointment was applied twice daily to all affected areas and left uncovered. PATIENT OUTCOMES : Dramatic reduction in surface area noted after 1 week with complete reepithelialization within 13 days. Patient remained for 33 days after wound resolution, and no recurrent ulceration was observed. Additionally, no residue accumulated in the wound bed as often occurs with some topical ointments, such as silver sulfadiazine. CONCLUSION: When utilized in conjunction with appropriate treatment of the underlying cellulitis, the use of Balsam ointment appeared to accelerate healing. The ointment maintained a protective moist environment without the need for a secondary dressing. The translucent property of the ointment also allowed visualization of the ulcers and did not stain clothing or buildup in the wound bed. Stan K. McCallon, PT, CWS, stanm@lifecare-hospitals.com, and Kelly Browning, RN, CWS, Director of Physical Medicine, Director of Wound Care, Shreveport, La PROBLEM: A 30-year-old Caucasian male suffered partial seconddegree burns to left anterior wrist and palmar regions due to fireworks accident. PAST MEDICAL MANAGEMENT: Despite selftreatment with silver sulfadiazine cream and gauze, patient was experiencing pain and swelling at burn site. Presented to author on post burn day 3 for initial medical treatment. CURRENT CLIN-ICAL APPROACH: Previous topical treatment was discontinued. Balsam Peru, Castor Oil, Trypsin ointment was applied to all affected areas twice daily, covered with a nonadherent dressing, and wrapped with a light compression bandage. Decision to use Balsam Peru ointment was based on author's experience with the use of ointment in healing of partial-thickness ulcers of multiple etiologies and information in the literature demonstrating the effectiveness of the ingredients in stimulating healing and providing bactericidal properties. PATIENT OUTCOMES: Patient reported immediate reduction in pain at the burn site following initial and subsequent applications of Balsam Peru ointment. Author noted reduction blister size following 1 day of treatment. Patient was able to return to work with no pain medications required. Ointment and dressing regimen was continued for a period of 8 days, resulting in complete reepithelialization and no further need for treatment. CONCLUSION: The use of Balsam Peru, Castor Oil, and Trypsin ointment worked very well in pain relief and healing of partial thickness burns. The ointment maintained a moist soothing environment and did not leave any residual buildup on the burned tissue. Additionally, on follow-up, the patient had no residual evidence of burn to the area. Stan K. McCallon, PT, CWS, stanm@lifecare-hospitals.com, and Kelly Browning, RN, CWS, Director of Physical Medicine, Director of Wound Care, Shreveport, La PROBLEM: A 53-year-old female with full-thickness ulcers to posterior neck complicated by periwound Candida albicans fungal infection. History significant for recent bacterial meningitis with seizures. PAST MEDICAL MANAGEMENT: Pressure wounds to neck were treated for 4 weeks with topical enzyme to assist with debridement of nonviable tissue. Despite some improvement, healing was complicated by periwound skin erosions and satellite lesions related to fungus. CURRENT CLINICAL APPROACH: A decision to use a Balsam ointment was made at this point based on success with partial-thickness lesions of different etiologies. Additionally, the literature demonstrates the effectiveness of the ointment's ingredients in stimulating healing and providing enzymatic debridement. After gentle cleansing, the entire area was dusted with antifungal powder followed by application of Balsam ointment twice daily to affected areas. PATIENT OUTCOMES: Within 7 days, all fungal-related erythema and periwound lesions were resolved and the antifungal powder was discontinued. Dramatic improvement was noted in overall tissue integrity and surface area of the pressure wounds. The largest of the 3 ulcers decreased in size from 10 cm 2 to 3.6 cm 2 in 1 week. Balsam ointment was continued for an additional 3 weeks. CONCLUSION: When utilized in conjunction with appropriate treatment of the underlying fungal infection, the use of the Balsam ointment appeared to accelerate the healing of fungal-related breakdown. The ointment also assisted in healing of the primary pressure ulcerations due possibly to vasostimulation. Of added benefit is the unique ointment delivery vehicle, which allows for instant visualization of the ulcers without staining clothing or accumulating in the wound bed. MS, RN, FNP, CWOCN, seltun66@msn.com, and Sara Leininger, PT, CWS, Mason City CLINICAL PROBLEM: Second-degree burns cause a significant amount of discomfort for the patient, require frequent dressing changes and pose a possible risk for infection and scarring. Treatment-scrub during daily shower and apply silver sulfadiazine cream BID. An 80-year-old male sustained superficial partialthickness thermal burns while cooking. Treatment-dressed with antibiotic ointment due to a sulfa allergy. CURRENT CLINICAL APPROACH: The wound was debrided of nonviable tissue and cleansed. A Hydrofiber dressing with ionic silver was applied to the burn, covered with large abdominal pads, and secured with tubular netting. The blisters and nonviable epidermis were debrided. A Hydrofiber dressing with ionic silver was applied to the burns and roller gauze applied to hold the dressing in place. PATIENT OUT-COMES: For both patients, complete reepithelialization occurred on day 14 when the Hydrofiber dressing with ionic silver was removed. No evidence of infection or scarring was noted. CONCLU-SION: Hydrofiber dressing with ionic silver provides cost-effective moist wound management support that has an antimicrobial barrier, wound absorption capabilities, and helps reduce painful dressing changes. The dressing also reduces product consumption and requires less nursing time, thus lowering costs of outpatient care. This dressing is an excellent alternative for second-degree burns in outpatient wound clinics. Claire Wilson, BSN, RN, CWON, cwilson@ogenix.net; Steven P. Schmidt, PhD; and Fred S. Hirsh, MD, Ogenix Corporation, Beachwood, Ohio CLINICAL PROBLEM: An 89-year-old white male in generally poor health presented to his dermatologist with a pressure ulcer on his left medial foot. The patient was not a surgical candidate (CHF, pacemaker, edema) and not diabetic. PAST MANAGEMENT: For 2 years, the dermatologist provided standard of care therapies in treating the wound including regular debridements and Regranex therapy for 6 weeks. The wound remained unhealed. At the age of 91, the patient developed osteomyelitis. Standard antibiotic therapies were inaugurated. CURRENT CLINICAL APPROACH: In addition to antibiotic therapy the patient agreed to have a continuous supply of oxygen delivered transdermally to the wound at a rate of 3 mL/hour from a device that derived pure oxygen from atmospheric air (EpiFLO) as the patient ambulates. 24/7 oxygen therapy was used in conjunction with a fully occlusive Johnson & Johnson 3″-x-4″ island dressing. PATIENT OUTCOMES: After 3 weeks of continuous oxygen and antibiotic therapies, the patient was able to ambulate without pain. The wound bed was characterized by new granulation tissue and reepithelialization. The antibiotic treatment was discontinued after 30 days, but the tiny, 2-oz oxygen therapy device was continued until full wound closure 11 weeks later. The wound remained closed for 36 months, the remainder of the patient's life. CONCLUSIONS: Therapeutic modalities such as transdermal sustained oxygen delivery may be beneficial in treating chronic wounds with osteomyelitis. 
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TREATMENT OF PARTIAL THICKNESS BURNS USING BALSAM PERU, CASTOR OIL, TRYPSIN OINTMENT: A CASE STUDY
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EXPERIENCE USING BALSAM PERU, CASTOR OIL, TRYPSIN OINTMENT FOR THE TREATMENT OF FUNGAL-RELATED SKIN IMPAIRMENT: A CASE STUDY
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CASE STUDIES: SECOND-DEGREE THERMAL BURN MANAGEMENT WITH A HYDROFIBER* DRESSING WITH IONIC SILVER IN AN OUTPATIENT WOUND CLINIC
610
TRANSDERMAL SUSTAINED OXYGEN THERAPY PROMOTES HEALING OF A CHRONIC PRESSURE ULCER IN A PATIENT WITH OSTEOMYELITIS: A CASE REPORT
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GOODBYE PYODERMA GANGRENOSUM! HELLO PROSTHESIS Sharon Anderson, BSN, MA, MSCC, swedishone@msn.com, Kaiser Permanente, Sacramento, Calif BACKGROUND: Pyoderma gangrenosum is an often-idiopathic ulcer with a characteristic appearance of an undermined necrotic blush edge and a peripheral erythematous halo. The current case deals with a 75-year-old female with a 4-year history of a nonhealing right leg ulcer with a biopsy diagnosis of PG, recalcitrant to medical management. The lesion progressed to a chronic underlying osteomyelitis. The purpose of this case report is to discuss the initiated management. METHOD: The patient was managed over 4 years with a wide spectrum of modalities, including topical debriding agents, Dakins dressing changes, vacuum-assisted closure, multiple silver agents, and Cyclosporin/Prednisone trials. The surrounding skin was severely atrophic due to the chronic steroid application. X-ray, nuclear studies and MRI studies demonstrated progression to bony involvement with osteomyelitis. The patient became despondent with the failed responses and continued pain and agreed to transtibial amputation. At 2-week follow-up the incisional wound demonstrated probable local PG recurrence. Wound care with enzymatic debridement, carboxymethyl cellulose (CMC) fiber dressing with ionic silver* was initiated a daily basis. RESULTS: Over a 2-month postoperative period the wound improved weekly with subsequent complete closure. CONCLUSION: Rapid successful wound closure was accomplished with (CMC) fiber dressing with ionic silver protocol of care. *AQUACEL Ag Hydrofiber dressing. AQUACEL and Hydrofiber are trademarks of E. R. Squibb & Sons, L.L.C.
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CHRONIC LEG ULCER AND THE USE OF PAPAIN-UREA CHLOROPHYLLIN DEBRIDING AGENT Laura Barnes, MSN, RN, WOCN, CWCN, APN-CNS, terry.coggins@smith-nephew.com, West Suburban Hospital, Oak Park, Ill CLINICAL PROBLEM: An 82-year-old male widow presented with a three month history of weakness, lower extremity edema, and a nonhealing lower leg ulcer. HISTORY: Osteoarthritis, CAD, type 2 diabetes, and leg pain at the wound site. The patient has never been evaluated for the PVD. Increased WBC count, increased warmth to touch at the site, increased leg pain, and a new onset of an odor from the wound noted by home care professional. The patient was hospitalized for cellulitis and started on IV antibiotics. The wound was surgically debrided and the WOCN was consulted. DESCRIP-TION OF PAST MANAGEMENT: Previous wound treatment included a calcium alginate dressing and a compression wrap. The patient was noncompliant with compression therapy secondary to increased pain. An enzymatic debriding ointment was employed without any change seen in the wound bed, the slough remained unchanged. CURRENT CLINICAL APPROACH: Topical treatment of lower leg ulcer was changed to a new Papain-Urea-Chlorophyllin enzymatic debriding agent* in a glycerin base. The enzyme is applied BID, covered with dry gauze, wrapped with gauze, and secured with tape. Papain-Urea-Chlorophyllin contains papain, urea, and sodium copper chlorophyllin. The author observed a decrease in odor and elimination of maceration with the new papain-ureachlorophyllin debriding agent. PATIENT OUTCOME: 10-26-04-LLE wound measured 22 cm × 20 cm with depth 0.5 cm; 90% slough tissue, 10% granulation tissue. Copious amount of serous drainage noted with erythema noted to surrounding skin. 11-09-04-LLE wound measures 15 cm × 14 cm with depth 0.2 cm; 25% slough tissue and 75% granulation tissue. Moderate amount of serous drainage noted and erythema decreased to surrounding skin. CONCLUSION This patient will be discharged and followed by home healthcare. The wound will continue to be treated with the new papain-urea-chlorophyllin agent until the wound is closed. *Gladase C is a product of Smith & Nephew. Paula Kotz, BSN, RN, C, CWOCN, etcsinc@excelonline.com, and Jane Fisher, BSN, RN, CWOCN, ET Consultant Services, Inc, Asheville, NC PURPOSE: To decrease the maceration in the periwound area of a chronic diabetic heel ulcer, maintain low bioburden, and improve wound dimensions. CLINICAL PROBLEM: A 75-year-old female with diabetes and neuropathy, complicated by chronic renal failure and hypertension. Ten-month old ulcer on the medial aspect of her right heel began as a small break in skin integrity, now measured 7.0 × 4.0 × 2.0 cm, stage III. Wound cultures were negative, and lab work was within normal limits. Osteomyelitis was ruled out by x-ray, blood sugars were controlled, vascular evaluation done, and off-loading was provided. Edema was initially managed by a multilayer high compression bandaging system, and then compression stockings. Despite local topical care using a variety of products, which included alginate, nonabsorbent silver, foam, and skin sealant, significant maceration was present in the periwound area. Wound dimensions remained unchanged. CURRENT CLINICAL APPROACH: The wound was cleansed with a wound cleanser and debrided with sharp instruments as needed each week. The periwound area was treated with a protective dressing. The wound as packed with an absorbent silver-coated antimicrobial barrier dressing. A foam heel dressing was applied. PATIENT OUTCOME: The dressing was changed every three days. Within 1 week, the periwound maceration was eliminated. Within 4 weeks, the wound measured 1.5 × 1.0 × 0.8 cm. Wound cultures remained negative. CONCLUSION: By using an absorbent silver-coated antimicrobial barrier4 dressing for 1 week, the chronic maceration that had been present in the periwound area for 10 months was eliminated. Low bioburden was maintained. Wound dimensions improved, which had previously not responded to conventional topical treatments. FINANCIAL ASSISTANCE/DISCLOSURE: Smith & Nephew, Inc. × 14 cm × 2 cm) was treated with nanocrystalline absorbent antimicrobial barrier dressing to prepare the wound for implantation of human fibroblast-derived dermal substitute. After 2 weeks of treatment, the dermal substitute was added to the left leg; right leg wound (11 cm × 7 cm × > 0.5 cm deep) was treated with the dermal substitute. DRESSING: Bilaterally nanocrystalline absorbent dressing then hydrocellular foam dressing held in place with stockinet. A contact layer of polyethylene was added after the implantations. Dressing changed daily to left leg due to heavy drainage, both lower leg dressings were changed q3d in the physician's office. Dressings were reinforced as needed. Patient continued with human fibroblast-derived dermal substitute application weekly to biweekly alternating legs. PATIENT OUTCOMES: On first dressing change at the physician's office, pain was reported as 7 on left and 5 on right-significant improvement. Wounds are reducing in size as well as pain. Donna Scemons, MSN, RN, FNP-C, CNS, CWOCN, donnahs@earth-link.net; Sura Faershtein BSN, RN; Ronna Forman, RN; Vladimir Gasparian, RN; Gloria Gutierrez, RN; Denise Hinson, RN; Barbara Percin, RN; and Erika L. Aldridge CLINICAL PROBLEM: A 62-year-old ambulatory male nursing home resident with AIDS, dementia, chronic renal failure, s/p abdominal hernia repair and hip fracture, developed a minor abdominal wound from tape stripping after he underwent a gastric tube (GT) insertion on 2/06/02. Subsequent peritonitis required GT replacement leading to reoccurrence of his ventral hernia, with loss of bowel adherent under the skin. Further surgery was excluded due to lack of imminent danger from the hernia, combined with his poor surgical risk. Over the next few months, both his hernia and the superficial wound continued to enlarge. PAST MANAGEMENT: After 4 months of unsuccessful bacitracin therapy, the WOC nurse was consulted. The painless, pink wound was 6 × 7 × 0.1cm and had peristaltic waves visible in the wound bed and intact but non-epithelizing edges. Nutrition and viral load remained acceptable throughout the treatment course. A daily to every-other-day regimen with, in sequence, hydrogel gauze, hydrocolloid, Dakin's washes, wound emulsion, mupirocin ointment and calcium alginate failed to support healing. The wound reached 8 × 10 × 0.2 cm. With the wound at the tip of the hernia, the contours made dressing adhesion problematic. The hernia retracted with lying and protruded with standing and sitting, despite temporary use of a poorly tolerated abdominal binder. CURRENT CLINICAL APPROACH: A composite dressing (hydrocolloid/Hydrofiber dressing/foam) was applied with resident sitting, with hernia in protrusion, beginning 6/01/04. Overlapping edges accommodated the abdomen's spherical shape. Reinforcement with a thin hydrocolloid provided extra adhesion for changing intraabdominal pressure. Dressing changes were reduced to twice a week. PATIENT OUTCOMES: After 5 months of composite dressing protocols used, the wound measures 3 × 4 × 0 cm, and continues to heal. CONCLUSION: The use of an adherent, conformable, absorbent composite dressing on an AIDS patient with a previously non-healing wound supported epithelization by maintaining a moist wound bed without edge maceration.
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RADIATED SKIN POST MASTECTOMY: A COMPLEX WOUND WITH ADVANCED WOUND TREATMENT
J WOCN ■ Volume 32/Number 3S Abstracts S9
In the presence of severe limb trauma with extensive soft tissue loss, reconstructive procedures are necessary to avoid amputation. This paper describes the use of a nanocrystalline silver dressing (NSD) in combination with a tissue replacement (Dermal collagen matrix-DCM), as a limb-salvage procedure in the management of two pediatric patients with extensive skin, bone and muscle damage due to traffic accidents. A 3-year-old boy suffered from an open femur fracture to the leg with injury to the femoral artery, femoral vein, and sciatic nerve. Following vascular and nerve reconstruction, the patient presented with a femoral thromboembolism and necrosis of the crural quadriceps, sural triceps, and back of the foot. The wound bed was prepared by applying a hydrogel impregnated gauze and covered with the NSD to avoid desiccation and infection of the exposed bone. Once the wound was clean, the DCM was applied and covered with the NSD to prevent infection. After 11 weeks, the patient was able to walk without assistance, despite sciatic palsy. A 9-year-old boy suffered severe trauma to the forearm. The boy sustained loss of the cubital artery, radial artery, median nerve and radial nerve, as well as part of the cubitus and radius. External fixation and arterial reconstruction with venous grafts were performed. The DCM was then applied and covered with the NSD to prevent infection. 2.5 months later the limb showed completed skin coverage. Some injuries are so severe that amputation may seem the only option. When the clinician tries to preserve the limb with skin substitute, the prevention of complications is important. The NSD was not only successful in the prevention of infection but also comfortable and cost-effective. Both patients were managed in an outpatient basis with dressing changes once weekly.
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USE OF NEGATIVE PRESSURE WOUND THERAPY (NPWT) TO MANAGE DRAINAGE AND STIMULATE CLOSURE OF A LARGE DEHISCED ABDOMINAL WOUND Shelly R. Burdette-Taylor, MSN, RN, C, CWCN, shelly@taylordhealth.com, Taylor'D Health Education/Consultation, San Diego
CLINICAL PROBLEM: Management of large dehisced abdominal wounds that drain copious amounts of fluid can be difficult in any clinical setting but especially in the home care arena. Use of negative pressure wound therapy allows for wound drainage management as well as mechanical closure of the wound in a timely manner. DESCRIPTION OF PAST MANAGEMENT: Use of negative pressure wound therapy initially in hospital after wound dehisced. Patient experienced pain in suction as well as during dressing changes. CURRENT CLINICAL APPROACH: Discharged to home with a large open abdominal wound with orders for home care to change dressing 1-2 times per day depending on saturation of dressing using calcium alginate. PATIENT OUTCOMES: Outcome indicators, such as length, width, depth, drainage amount, and pain were assessed and measured weekly. Dressings were changed 2 times per week. Significant improvements were obvious in 7 days with wound drainage reduction and 14 days with reduction in overall size of the wound. This 33-year-old female status post gastric bypass patient continued therapy for 8 weeks then chose to complete the healing process using a hydrogel moistened gauze dressing and changed it every other day. CONCLUSION: Negative pressure wound therapy has been proven to stimulate closure by encouraging granulation tissue formation, collecting the drainage, reducing the edema while stimulating angiogenesis, which increases the blood flow at the same time promoting comfort by protecting the skin, and reducing pain with low continuous pressures. It is possible to deliver subatmospheric pressure with the use of a portable suction pump and traditional wound care products. Gauze, drains, transparent films, and, if indicated, an enzymatic debrider, or antimicrobial such as silver, cadexomer iodine, or diluted Dakin's solution may be used. It is an option available, cost-effective, simple, and easy to use. Annielyn A. Ocampo, BSN, RN, aocampo@madonna.org, Madonna Rehabilitation Hospital, Lincoln, Neb CRITICAL PROBLEM: An 85-year-old white male who was playing cards at a friends house, took a wrong step on his way home and had immediate pain in right ankle with deformity and ended up at the ER. Patient has history of open reduction internal fixation at right ankle, which has been verified when x-rays were taken, further revealed fracture of the fibula at the superior end plate, nondisplaced distal fib fracture. Patient is a poor surgical candidate because of elevated albumin, diabetes, and peripheral vascular disease. Patient ended up with soft cast at right foot and ankle. Left leg with full strength and sensation. At admission to this facility, patient was 1 assist with ADLs and 2 assists for transfers. When cast was removed after 1 1 ⁄ 2 months, right anterior medial ankle revealed eschar formation which was debrided and large extensor tendon was exposed. DESCRIPTION OF PAST MANAGEMENT: Mafenide acetate 5% topical solution via wet to moist dressings has been initiated with weekly wound debridement for at least 2 months with EMLA application 1 hour prior to wound rounds visit. CURRENT CLINICAL APPROACH: Half-strength hypochlorite solution via wet to moist dressing was initiated after minimal results have been observed and every 2 weeks sharps debridement which includes tendon debridement. PATIENT OUTCOMES: After 2 weeks' use of hypochlorite solution via wet to moist dressing, granulation tissue formation has increased, wound dimension became smaller, and epithelial formation at wound edges. CONCLU-SION: Decreased debridement time, improved patient outcomes and faster wound healing. FINANCIAL ASSISTANCE/DISCLOSURE: No financial assistance was received for this study. REFERENCES: The International Journal of Lower Extremity Wounds, Vol. 2, No. 4, 189-197 (2003) Susan M. Cooper, MB, MRCP et al.
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THE USE OF VACUUM-ASSISTED CLOSURE IN COMBINATION WITH A NANOCRYSTALLINE SILVER DRESSING-A CLINICAL EVALUATION
Uberto Giovannini, PhD, ubertogiovannini@yahoo.com, San Carlo Hospital, Milan The topical negative pressure (TPN) has become a widely accepted technique in the management of chronic and acute wounds. Ulcers that are difficult to close or heavily colonized may still remain a challenge. The aim of this study was to evaluate the efficacy of a nanocrystalline silver dressing (NSD) in difficult-to-heal colonized wounds in combination with TPN, with regard to bacterial load, frequency of dressing changes and patient comfort. This was an uncontrolled, prospective study of a case series of 9 patients with a variety of heavily colonized non-healing wounds. Microbiologic swabs were taken weekly. Dressing regime consisted of cleansing of the wound with an antiseptic solution, the application of the NSD to the surface of the wound (which was covered with a carbonate sponge). The site was sealed with an adhesive transparent dressing drape. Negative pressure of −125 mmHg was applied. A marked clinical improvement was noticed in all the wounds. There was decreased erythema of the wound edges and decreased exudate. The swabs showed a decrease in the wound surface bacterial load. Only in one case were systemic antibiotics administered (for 1 week). Within 14-21 days, the wound bed appeared clean and healthy granulation tissue was present in all wounds. At this point, the TPN therapy and NSD were discontinued and a different therapy was adopted. All the wounds closed. In 4 of the wounds, skin graft was used for wound closure. The remaining 5 wounds closed with other therapies. It would appear from the results obtained that there was positive synergy between the NSD and the TPN system. This association was effective in the management of infection; it also increased patient comfort through reduced dressing changes. Theresa M Pittman, BSN, RN, CWOCN, booboofixerrn@nycap.rr.com, Ellis Hospital, Glenmont, NY OBJECTIVES: After participating in this activity, wound care providers will be able to (1) identify the benefits and cost effectiveness of moist wound healing, (2) discuss the elements of comprehensive wound management program, (3) identify the benefits of autolytic debridement using Hydrofiber and composite dressing. PROBLEM: An 84-year-old female hospitalized with stage 4 pressure ulcers on multiple turning surfaces (largest 15 cm and one with 40-50% of wound bed exposed bone). RATIONALE: Wounds do not occur or heal independently of the rest of the body. A comprehensive wound management program to prevent complications and promote wound healing is indicated. METHOD-OLOGY: Wound environment was manipulated containing the drainage, preventing maceration, fostering moist wound healing, and changed every 2-3 days. A Hydrofiber, Composite dressing, and Hydrocolloid were used as indicated. Pressure redistribution, physical therapy, and dietary supplements were included. RE-SULTS: Two of 4 ulcers healed within 4 months, despite multiple barriers to healing. The remaining ulcers showed satisfactory reduction in size. Cost savings were achieved by efficient dressing use and nursing time. Patient and staff verbalized satisfaction in the response to and ease of treatment, as well as effective pain management and decrease use of analgesics. CONCLUSION: The use of advanced wound care dressings resulted in a positive outcome for a complex high-risk patient. Judith LaJoie, RN, C, CDE, ACHRN, DAPWCA, chrnnurse@aol.com, Kingsbrook Jewish Medical Center, Brooklyn, NY CLINICAL PROBLEM: We were exploring new treatments at our wound care center to resolve difficult nonhealing venous stasis ulcers. These ulcers often present with increased exudate, odor, and deteriorating wound bed characteristics due to increased bioburden. As a result, time to closure is extended and costly. METH-ODS: Random case selection of patients that had venous stasis ulcers and had been previously treated without significant improvement with foam and compression. The new prescribed course of treatment was cleansing with wound cleanser, the addition of the silver impregnated calcium alginate and CMC dressing* under a 4-layer compressive wrap. Dressings were done weekly and prn. Wounds were evaluated weekly for reduction in edema, wound size, exudate, and wound bed characteristics. DISCUSSION: Proper wound bed care and inclusion of a silver alginate and CMC dressing* under compression provided for improved exudate absorption and reduction of the bioburden directly at the wound level. Silver is a known broad-spectrum antimicrobial and deters fungal growth. In a controlled sustained-release ionic formula, it can reduce bioburden, is not cytotoxic, stimulated granulation, and promoted wound closure. CONCLUSION: Patients and staff reported satisfaction with the product. Wounds that received the silver alginate and CMC* closed faster than those receiving compression and foam therapy. Addition of silver in conjunction with a 4-layer compression had a positive impact on patient care outcomes. FINANCIAL ASSISTANCE/DISCLOSURE: Products were provided by Medline Industries for these case studies. 
CASE STUDY: CARE OF PRESSURE ULCERS USING PRINCIPLES OF WOUND HEALING
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THE USE OF IONIC SILVER CALCIUM ALGINATE AND CARBOXYMETHYLCELLULOSE IN RESOLVING THE VENOUS STASIS ULCER
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The Prospective Payment System (PPS) is influencing home health agencies wound care practices. Many of the agencies wounds are admitted as non-healing on OASIS. The focus has become decreasing the time for wounds to close in a cost-effective manner. Ideal wound management must incorporate dressing materials that are nontraumatizing and capable of managing exudate and maintaining moisture balance while providing antimicrobial properties. PAST MANAGEMENT: A variety of dressing categories were used in the past, including several with silver. CLINICAL APPROACH: Random selection of patients included those with post-op wounds, diabetic, venous stasis, and pressure ulcers to evaluate the performance of a new ionic silver impregnated calcium alginate and carboxymethylcellulose (CMC) dressing* as a topical wound therapy for colonized, chronic, or acute wounds. The dressing was selected for its enhanced exudate handling capacity while forming a gel that promotes a moist healing environment. The controlled-release silver component was chosen for the ability to control a broad spectrum of bacteria and fungi. OUTCOMES: Positive outcomes for management of moderate to large volumes of exudate, decreased periwound irritation, and decreased time to closure were realized. Patients also noted a decrease in wound odor and pain. Application of the silver dressing to the wound bed provided antimicrobial protection, allowing chronic wounds that were previously unresponsive to multiple treatment regimes achieved closure by producing healthy granulation tissue and in some instances epithelial regeneration in several weeks. Nursing visits decreased from daily to 1 to 3 times a week. Education of caregivers was accomplished due to ease of dressing application. CONCLUSION: The dressing proved to be a cost-effective alternative to help manage multiple wound scenarios, resulting in increased patient and staff nurse satisfaction. A PPS cost savings was realized for our home care agency. DISCLO-SURE: *Maxorb Silver samples provided by Medline Industries, Inc., Mundelein, Ill.
Patients who undergo surgery in hospital are likely to be discharged earlier due to increasing pressure on hospital beds, in a socialist healthcare system, as in the UK. Community nurses involved in wound care are therefore likely to encounter surgical wounds healing by both primary and secondary intention (Dowsett, 2002) . Surgical wounds have been defined as clean, dirty, or contaminated. Patients with dirty or contaminated surgical wounds are more likely to develop wound infections than those with clean wounds (Briggs, 1997) . Other preoperative and perioperative factors that are associated with increased risk of infection include site of surgical incision, length of preoperative stay, hair removal, antibiotics, methods of wound closure, postoperative care, and wound dressings. Infection can lead to several complications in primary wound healing and may cause the wound to break down and heal by secondary intention, cause a delay in healing, require further hospitalization, and may even be life threatening. This poster presentation will illustrate the use of a silver-coated antimicrobial barrier dressing in a short case study series of 3 patients. All patients have presented with acute injuries that have developed complications and infection. Although this type of dressing has been widely used in chronic wounds, such as lower extremity wounds and pressure ulcers with excellent results, there has been little work published in the UK of its use in acute wounds. Sonja Rivers, BSN, RN, CWOCN, sonja.rivers@northmemorial.com, and Linda Roehl, BS, RN, CWCN, COCN, North Memorial Health Care, Robbinsdale, Minn CLINICAL PROBLEM: It is widely accepted that age-related changes place the frail elderly patient at high risk for skin breakdown. Chronic medical conditions, medications, malnutrition, and environmental hazards in the healthcare setting, such as bed rails and wheelchairs, compound this risk. Treating wounds when the surrounding skin is fragile poses a clinical challenge for nursing. A frail 83-year-old woman was admitted to the hospital with anemia, weakness, lower extremity wounds, and skin tears after several falls at a long-term care facility. Her medical history was significant for PVD, DVT, and multiple sclerosis. PAST MANAGE-MENT: Prior to her hospitalization, saline gauze was being used on the leg wounds and skin tears causing painful dressing removal and trauma of surrounding tissue. CURRENT CLINICAL APPROACH: Treatment goals: decrease pain and frequency of dressing changes, protect fragile skin, absorb drainage and wick it away from wound and surrounding tissue, autolytic debridement, and wound visualization. While hospitalized, a clear absorbent dressing was applied to the skin tear on her forearm and lower extremity wounds. Prior to dressing application an alcohol-free barrier film was used for additional protection from wound fluid and adhesives. PATIENT OUTCOMES: During the time the dressing was in place, staff was able to visualize the wound and periwound skin. After 4 days the dressing was removed without trauma to the surrounding fragile skin. The patient denied pain during dressing wear and removal. Overall, improvement was noted with less erythema and inflammation as well as evidence of autolytic debridement in all wounds. CONCLUSIONS: The clear absorbent acrylic dressing was effective and met our goals for wound treatment. Ability to visualize the wound through the dressing provided significant benefits. It prevented wound disruption and pain associated with dressing changes, while saving nursing time and supply cost. CURRENT CLINICAL APPROACH: After discussing treatment options and lack of progress with family and home health agency, it was determined that a 2-week trial of polyacrylate gel pad (PGP) may facilitate autolytic debridement. Wounds measured 11.0 × 5.5 × 100% necrotic slough at onset of daily PGP treatment. The goal was to obtain a viable granulating wound base prior to starting traditional paste bandage with light compression. PATIENT OUTCOMES: After 7 days of treatment, the wound measured 10.7 × 5.5 × 0.15 with a 50% slough base and mild periwound erythema. At the end of 14 days of treatment, the wound was 11.0 × 6.0 × 0.15 with a 95% granulation base. Patient tolerated treatment well. CONCLUSION: Despite aggressive wound care, chemical debriding agents proved ineffective for this patient. A 2-week use of PGP autolytically debrided the wound base, enabling skilled nursing visits to be decreased to twice a week with traditional paste bandage and light compression. At the end of 3 months, there were now 3 distinct areas measuring 0.3 × 0.6 × +0.05, 2.0 × 1.5 × +0.01, and 1.2 × 2.9 × +0.01. SN visits were then reduced to once per week. Four months after PGP treatment completed, patient wound was 0.8 × 0.5 × 0.05. Deb P. Schimmelpfenning, BSN, RN, CWCN, COCN, KVSCHIMM@bitwisesystems.com, and Sharon K. Mollenhauer, RN, BSN, CWCN, COCN, Proctor Hospital Wound Clinic, Peoria, Ill PROBLEM STATEMENT: Wound centers are challenged by complex patients. A plan of care must address all underlying factors including wound management to promote healing. A 31-year-old paraplegic male with controlled type 1 diabetes presented with 1-month-old burns on his right trochanter measuring 5.4 cm × 3.9 cm and 0.6 cm × 0.4 cm. The noninfected wounds were covered with 80% slough and softening eschar. DESCRIPTION OF PAST MANAGEMENT: The wounds were previously treated with Silvadene. The patient denied use of a pressure reducing sleep surface; a Jay II wheelchair cushion was noted. CURRENT CLINICAL APPROACH: Pressure reduction was accomplished using a static air mattress overlay. Pressure ulcer education was provided. A novel clear acrylic dressing* was chosen to provide autolytic debridement with minimal dressing changes, absorption of drainage, visual assessment, ease of application, and ability to continue daily showers and transfers. Dressing changes were scheduled twice weekly intending to extend wear time as drainage decreased. A newborn May 2002, with pentalogy of Cantrell variant with a skin covered cardiac silhouette, sternal cleft, diaphragmatic hernia, pericardial agenesis, and a large upper abdominal omphalocele, remained in the hospital for 6 months as the respiratory management addressed her pulmonary hypoplasia while conservatively managing the omphalocele. Initially, wound management consisted of .25% silver nitrate solution, as daily dressings. Treatment plan changed to twice daily NS wet to dry dressings as neoepithelialization progressed. Complete healing of all granulation areas was considered necessary to lessen postoperative complications for particularly the sternal closure and prosthetic repair of the diaphragm. Wound management was modified as follows: February 23, 2004-wound measurements: 4.0 cm × 3.7 cm; treatment: SIS dressing applied to wound bed. Silicone dressing layered on SIS. Normal saline moist gauze used on top of silicone layer changed daily. Dressings kept in place with a role of woven gauze. March 16, 2004-wound measurements: 4.0 cm × 3.5 cm. Treatment: SIS dressing every 5 to 7 days. Wound gel replaces NS gauze. Mother using vitamin E oil on the newly healed skin. Everything else the same. April 29, 2004-wound measurements: 1.5 cm × 2.5 cm. Treatment: Remains the same. July 15, 2004-wound measurements: 3 cm × 3 cm. Treatment: mother used silver nitrate sticks on hyper-granulation tissue. Stopped using wound gel. Stopped using gauze. Started using silicone foam cover dressing changed every 3-5 days or as needed. Gauze role used over cover dressing to keep out little fingers. August 19, 2004-wound measurements: healed. Treatment: using silicone foam cover dressing ONLY for protection of new skin. The utilization of a silicone foam cover dressing allowed the wound to be evaluated without disturbing the SIS dressing itself or the underlying neoskin. It is felt the limited manipulation of the wound with this technique accelerated wound closure. Janell McNeill, MSN, CRRN, CWS, CWCN, janellmcn@comcast.net, Wound Healing Center at Kessler Memorial Hospital, Hammonton, NJ STATEMENT OF CLINICAL PROBLEM: A 68-year-old male physician presented with a left medial aspect ankle wound resulting from an injury 1 month earlier. The patient had a past history of fractured left femur, multiple venous leg ligation procedures, and a current history of coronary artery disease, hyperlipidemia, and hypertension. ABI was within normal limits. Valvular incompetence was noted on venous Doppler exam. The patient was diagnosed with a venous wound with minimal arterial disease and was a candidate for compression therapy and aggressive wound management. DESCRIPTION OF PAST MANAGEMENT: The wound was debrided on the initial clinic visit. Compression wraps were ordered with moist wound healing approaches. The patient was compliant with visits and self-administered treatments. The wound showed immediate progress to healing in the first 14 days of treatment with a wound volume percentage decreasing to 80%. The wound volume remained essentially unchanged for the next 126 days of treatment in spite of regular debridement, compression, and various local treatments. CURRENT CLINICAL APPROACH: An ionic silver dressing (based on nanocrystalline technology) was implemented under compression wraps at day 140. After 14 days, the wound progressed to 90% wound healing. After a total of 56 days, the wound was progressed to complete closure. PATIENT OUTCOME: The introduction of an ionic silver topical dressing seemed to be the contributing factor to complete wound healing in a venous disease wound that lacked progress during 126 days of treatment. A retrospective review of actual costs for the patient and insurance company from day 70 to day 140 when the wound did not progress was estimated to be $6154. CONCLUSIONS: Treatment protocols outlining the appropriate timely use of ionic silver in wound management may demonstrate to be cost-effective in decreasing both treatment time and costs and justify the cost of ionic silver dressings. Marlene L. Balik, BSN, RN, CWCN, marmomrn@yahoo.com; Dariusz Sokolowski, PT; and Douglas R. Solway, DPM, FACFAS, Bethany Terrace Nursing Centre, Morton Grove, Ill CLINICAL PROBLEM: A 91-year-old female was admitted to a long-term care facility. The staff encouraged her to ambulate with a walker, while wearing older worn-out shoes. Two days after admission, a large blister was noted on the left heel. DESCRIPTION OF PAST MANAGEMENT: This unstageable pressure ulcer was assessed by the CWCN, 5.5 × 8 cm, noted to be a closed, flat, soft, dry, gray blister with a nonvisible wound bed and periwound erythema. The plan was to maintain the blister intact. Foam dressing was applied and non-weight bearing to the affected heel with an off-loading boot was used. The blister developed into a necrotic ulcer. Three weeks after it developed the eschar loosened at the edges with foul-smelling serosanguinous drainage. The patient was admitted to the hospital, returned 4 days later with eschar still adherent, although separating at the edges. CURRENT CLINICAL APPROACH: An interdisciplinary team comprising the certified wound care nurse, physical therapist, and podiatric wound care specialist, collaborated on the assessment and treatment modalities. The podiatric wound care specialist performed a sharp debridement and continued to assess this ulcer 1 to 2 times monthly. The physical therapist initiated high-volt galvanic electrical stimulation (high-voltage pulsed current) to the left foot/ankle to promote circulation and healing 5 times weekly. Enzymatic debridement was the primary treatment until a deep crevice was identified at the posterior end of this stage III ulcer that required daily packing with a calcium alginate dressing. The CWCN assessed and treated this ulcer twice weekly. The treatment that continued until healing was electrical stimulation, calcium alginate primary dressing and foam secondary dressing. PATIENT OUT- CLINICAL PROBLEM: C.R. presented on July 22, 2004, with a 2-month-old traumatic wound on her left lateral leg. She had been seen in the emergency department for evaluation but was told no dressing was required as it was just a "bruise." However, an open wound eventually developed with no improvement note with use of Neosporin. CLINICAL APPROACH: On the initial exam, the wound measured 4 cm × 3 cm with a small area of undermining noted from the 11 to 3 o'clock positions (depth = 0.8 cm). The wound bed was 50% clean, deep reddish tissue and 50% firmly adherent yellow slough. An enzymatic debriding ointment (Gladase-C by Smith & Nephew) and dressing were ordered; to be changed daily. Further complicating C.R.'s care was venous insufficiency. Six days later, the left lateral wound was reassessed and measured 3.6 cm × 2.8 cm with no improvement in the undermining. The wound appearance had improved significantly with the majority of the visible wound bed filled with beefy red granulation tissue, although a thin rim of slough/fibrous tissue was noted along the proximal aspect of the wound. PATIENT OUTCOME: On day 21, the primary wound site continued to decrease in size. A new wound was noted adjacent to the primary wound with no known injury. Both wound sites were now filled with healthy pink granulation tissue. The dressing therapy was changed to a silver-impregnated calcium alginate dressing. C.R. was healed by day 68. DISCLAIMER: No financial assistance was provided for this case study. Joy E. Schank, MSN, RNC, APN, CWOCN, schankco@htva.net, Schank Companies, Himrod, NY STATEMENT OF CLINICAL PROBLEM: Burn pain can be excruciating, even for patients with a small burned area. The following cases demonstrate a pain reducing approach to patient healing. DESCRIPTION OF PAST MANAGEMENT: The first individual is an 83-year-old female who sustained a heating pad burn. Past treatment included antibiotics and dressing changes with an antibiotic ointment. The second patient is a 44-year-old female with a motorcycle burn. Prior treatment included dressing changes with silver sulfadiazine. The final patient is a 65-year-old male who sustained a welding burn injury. Past treatment included dressing changes with an antibiotic ointment, plus antibiotics. CURRENT CLINICAL APPROACH: Treatment for the 83-year-old included application of a Hydrofiber dressing. Hydrofiber was selected to absorb the exudate that would occur due to the autolytic process, thus prolonging the wear time. The Hydrofiber was covered with a hydrocolloid and bordered with tape. Sharp debridement was not performed for the patient with the motorcycle burn, due to her significant discomfort. Instead a Hydrofiber dressing covered with a composite dressing with Hydrofiber technology was selected. These dressings were used because of the amount of slough that would be liquefied, requiring a high exudate management system. Both a silver and a composite dressing with Hydrofiber technology were applied for the patient with the welding burn. PATIENT OUTCOMES: The patients healed and stated how much it meant that their pain had decreased with this approach. CON-CLUSIONS: Occlusion of the burns offered these patients pain reduction on their initial visit. This gives an advantage to the clinician as the clinician learns to expect this benefit. Pain management with occlusive dressings is simple to teach. Each patient related they he or she was amazed with the pain reduction and wondered why more providers did not use the treatment. The second patient with a full-thickness heel ulcer is managed with daily calcium alginate dressings. The third patient has daily dressing changes with a hydrogel. CURRENT CLINICAL APPROACH: Dressings often fail to adhere to wet skin and dollars are lost with failed attempts. Protective barrier ointment containing zinc and carboxymethylcellulose becomes an excellent option for this first patient with denuded skin. The second patient demonstrates cost reduction through weekly dressing changes. These dressing changes consist of a Hydrofiber dressing covered with a composite dressing, also containing Hydrofiber technology. This manages the exudate, allowing a 7-day wear time. An effective strategy decreases the management cost of the third patient. He has type 1 diabetes with infected full-thickness heel and foot ulcers. The offending organisms are MRSA and pseudomonas aeruginosa. The silver barrier dressing with Hydrofiber technology reduces the risk of infection and manages exudate. A hydrocolloid with polymer technology provides additional absorption. PATIENT OUTCOMES: Modern wound care technology provides the patient and clinician management options that actually can reduce the overall cost of care by reducing dressing changes and clinician visits. CONCLUSIONS: Modern wound technology, combined with appropriate pressure reducing strategies, is the lifeline for the patient, clinician, and healthcare organization in this era of shrinking budgets. This technology often equates to substantial cost savings. our approach and including it in nursing orientation has helped enhance quality of care and reduced the amount of WOC nurse time spent teaching staff about this topic. OBJECTIVE: An effective pressure ulcer prevention program must include measures to reduce the risks associated with fecal and urinary incontinence. Staff providing care to inpatients with incontinence need ongoing information, instructions, and encouragement to manage this challenging problem. At Moses Cone Health System we follow a simple, straightforward protocol to communicate the importance of regular toileting, adequate fluid intake, and timely use of a combination cleanser, moisturizer, and barrier product. The use of an effective skin product simplifies the process, enhancing staff compliance. OUTCOMES: The success of this program in preventing and managing incontinence-related skin problems will be described using 3 case examples. The featured cases were cared for in our 15-bed geriatric unit, where up to 50% of the patients are incontinent of stool or urine. The strengths and challenges of this incontinence management plan will be described and suggestions will be made for use of this program in other settings. CONCLU-SION: This program provides guidance to staff caring for inpatients with incontinence. While not comprehensive, it outlines 3 simple, key interventions for staff to follow that can reduce the risk of skin injury related to incontinence. It can be easily adapted for use with patients in other settings. FINANCIAL ASSISTANCE/ DISCLOSURE: The support of Hollister Incorporated for this project is gratefully acknowledged.
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MANAGING DIARRHEA AND FECAL INCONTINENCE: RESULTS OF A PROSPECTIVE CLINICAL STUDY IN THE ICU
Kimberly Howe, RN, khowe@forumhealth.org; Anantha Padmanabhan, MD; Mark A. Stern, MD; and Jeffrey Williams, MD, Forum Health/Western Reserve Care System, Youngstown, Ohio RATIONALE AND PURPOSE: Managing fecal incontinence and diarrhea challenges intensive care unit (ICU) staff to control the fecal output and protect the skin. A new medical device system (FMS*) uses an inflated balloon to retain a tube within the rectum while an external pouch collects fecal material to maintain temporary continence in subjects with uncontrolled diarrhea. OBJECTIVE: Safety and performance of an innovative system (FMS) for managing fecal incontinence was evaluated in a prospective noncomparative study in two ICUs. METHODOLOGY: Ten subjects with diarrhea and incontinence in two ICUs had the FMS inserted. Endoscopic proctoscopies of the rectal vault assessed condition of the anorectal mucosa preinsertion and postremoval. Investigators assessed ease of FMS insertion and removal, device retention and leakage, patient comfort, perineal skin condition, and odor during FMS use. OUTCOMES: The FMS performed well for 1 to 13 days with no safety issues among any of the 10 subjects, though 2 died during the study due to non-product-related illnesses. It was judged easy to insert and remove with easy-to-follow instructions. All subjects retained the device without difficulty or external securing devices during the study, except 1 with a weakened internal sphincter, who expelled it after 8 hours. During a total of 65 daily assessments, nurses reported the FMS effective and time efficient in managing fecal incontinence, with no odor or discomfort reported and limited leakage. During FMS use, perineal and buttock skin condition were maintained or improved on all but one patient who developed patchy redness on the buttocks. CONCLU-SIONS: The FMS was well accepted, performed well with no safety issues for all patients, and helped reduce risk of perineal and buttock skin breakdown. PRODUCT NOTATION: *Flexi-Seal Fecal Management System, ConvaTec, Princeton, NJ, USA. Flexi-Seal is a registered trademark of E. R. Squibb & Sons, L.L.C.
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OSTOMY CARE EDUCATION FOR ACUTE CARE REGISTERED NURSES Jane V. Arndt, MS, RN, CWOCN, CNS, jva@pvhs.org; Mary J. Hansen, BSN, RN, CWOCN; and Cyrilla J. Haverkamp, BSN, RN, CWOCN, Poudre Valley Hospital, Fort Collins, Colo PURPOSE: To create an educational program for RNs in our facility. OBJECTIVES: Increase RN comfort, knowledge, and competence with ostomy appliance changes. Increase compliance with ostomy appliance changes being done in a timely manner when the ET Nurse is not available. Our 235-bed acute care hospital is fortunate in having good administrative support for wound ostomy continence services. We have 1.5 FTEs in our department. While this allows time for complicated wound care and ostomy teaching, it does not provide specialized care for ostomy patients around the clock. PROBLEM: New and experienced ostomy patients were not getting the assistance needed from the staff RN to change their appliances in a timely manner. This led to decreased patient satisfaction with their stoma and hospital stay and to increased peristomal skin breakdown. RNs reported a low level of comfort with ostomy care. SOLUTION: To address the educational need, the CNS attended staff meetings and demonstrated an appliance change, explaining the use of different ostomy care products. Next, the CNS set up an educational program at the surgical unit's annual mandatory competencies where every nurse used a model to do an appliance change. Each nurse was also given copies of patient education materials to become more familiar with ostomy care. The last step was the creation of a 9-minute video showing a detailed appliance change and how to empty and rinse a pouch. The video is short enough to be reviewed by staff as needed and to use in new employee orientation. OUTCOMES: Complaints from patients about ostomy care have been nonexistent for the last 6 months. Nurses state they feel more confident in providing stoma care. An unexpected outcome is how well received the video has been by patients. We now show it routinely to new ostomy patients. Jane A. Fellows, jane.fellows@duke.edu, and Michelle C. Rice, Duke University Hospital, Durham, NC TOPIC: In the pediatric department of a large tertiary care hospital, there are frequently children with ostomies. These children range in age from preterm infants to adolescents. Many of the staff had little education about the care of these patients, and the products available were difficult to locate and not adequate for the needs of this population. Nurses reported changing pouches multiple times per day. PURPOSE: A program was developed by the ostomy nurse clinicians to meet the needs of the staff in providing ostomy care. An assessment of products was done and the need for additional products was identified. As there are several hundred nurses in the pediatric department it was felt that a variety of approaches would be needed for staff education. Nurses were surveyed about tools that would give them the most effective resources for information. OBJECTIVES: (1) increase staff knowledge about ostomy care, (2) decrease frequency of pouch changes, (3) decrease cost associated with frequent pouch changes, (4) improve care for patients by decreasing the discomfort and risk of skin breakdown with pouch leakage and frequent adhesive removal, and (5) decrease in handling and opening of the isolette for preterm infants. OUTCOME: The product line was increased to provide an improved selection of pediatric ostomy supplies. A comprehensive program was designed for staff education, including unit-specific resource manuals, a CD/slide program on the nursing station computers, and inservice education. Staff surveys are being done to evaluate how the nurse's education needs are being met. Pouch changes have decreased to 1-2 times a day on preterm infants and several times a week on older babies and children. The decrease in supply usage is still being evaluated. Donna Loehner, BSN, CWOCN, donna.l.loehner@lahey.org; Kerry Casey; Liz Lemiska, BSN, RN, CWOCN; Ann Navage, MSN, APRN, CWOCN; Stacey Roberts, BA, RN, CWOCN; Lisa Hill, MSN, RN, CWOCN; and Jo Catanzaro, MSN, RN, CWOCN, Lahey Clinic, Burlington, Iowa PURPOSE: A wider outlet for an integrated closure ostomy pouch was developed (Product A) to make emptying easier for ostomy patients producing thicker effluent. The purpose of this clinical investigation was to compare Product A to a standard integrated outlet (Product B). OBJECTIVES: The primary objective was to determine if people with colostomies would find the new wide outlet easier to handle than standard outlets. Secondary objectives, among others, was to demonstrate that Product A would not leak more frequently and was easier to empty than Product B. This comparative open cross-over randomized multicenter investigation was conducted in the United States in 2004. Thirty one people with colostomies used each type of pouch (Products A and B) for 1 week. The evaluation parameters were based on 5-point scales, with 5 being best. OUTCOME: Criterion of success was fulfilled with Product A being significantly easier to handle than Product B (P = .001). There was an overall preference for Product As outlet (93%) to Product Bs outlet (7%) (P < .001) due to wideness of outlet, easy to clean, and presence of Velcro dot for easy emptying. Other significant differences in favor of Product A were general handling (P = .001), emptying (P < .001), cleaning (P < .001), and hygiene (P = .012). The position of the filter on Product A was found to be significantly better (P = .002). CONCLUSION: All criteria of success were fulfilled, demonstrating statistical significance in favor of Product A in the following parameters: general handling, preference of outlet, emptying, hygiene, and cleaning. Overall, people with colostomies preferred Product A (80%) to Product B (20%) (P = .001), due to ease of emptying and ease of handling. FINANCIAL ASSISTANCE/DISCLOSURE: This investigation was initiated and sponsored by Coloplast A/S. Product A = Assura EasiClose Wide Outlet. Product B = Assura EasiClose. In a large tertiary-care hospital with a significant population of patients with ostomies ranging in age from preterm infants to elder adults, peristomal skin complications pose frequent challenges for healthcare professionals and caregivers. This includes peristomal skin breakdown, which impacts wear time, increases cost, usage of supplies, and patient discomfort. A need for an absorbent nonadhesive dressing was identified. PURPOSE: To decrease healing time while maintaining an effective pouching system, a foam dressing with silicone technology was used in the treatment of peristomal skin breakdown. Objectives: (1) to improve healing of peristomal skin complications, including pyoderma gangrenosum, pressure related skin breakdown, irritant dermatitis, skin stripping from adhesives, and vesicular skin eruptions; (2) to decrease pain associated with peristomal skin complications; and (3) to reduce the trauma associated with frequent pouch changes. OUTCOME: Product trials are in progress. Preliminary results show this to be an effective dressing for peristomal skin complications with the added benefit of ease of use. Photo documentation is ongoing. (2002) did a met-analysis study comparing chlorhexidine with povidone-iodine solution for vascular catheter-site care. The results suggest that there is a decreased incidence of central line infections when chlorhexidine is used compared to povidone-iodine solution. PURPOSE: The purpose of the project was to compare two central line site care methods (chlorhexidine vs Betadine and alcohol) and the effect on central line infection rates in the oncology population. METHODOLOGY: Data were collected retrospectively via chart review on central line infection rates per 1000 catheter days in the adult oncology population. The protocol for central line site care was changed to chlorhexidine. Approval was obtained from the physicians, nursing clinical practice, and the infection control committee. The staff was provided with education via inservices, via written information, and by watching a video on the new protocol on central line care. Data were then collected prospectively on central line infection rates per 1000 catheter days. RESULTS: Central line infection rates decreased from 8.7 to 1.6 after implementing the new central line site care protocol (chlorhexidine). CONCLUSION: Results from this study indicate that central line care using chlorhexidine is superior to care using Betadine, as shown by the decreased central line infection rates.
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COMPARATIVE CROSS-OVER RANDOMIZED INVESTIGATION OF TWO DRAINABLE OSTOMY POUCHES WITH INTEGRATED CLOSURES
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USE OF SILICONE PRODUCTS IN TREATING PERISTOMAL SKIN BREAKDOWN
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abdomen, there could be several difficulties to manage both. First, it is difficult to perform wound dressing and pouching independently, and one procedure involves the other every time. Second, ostomy/fistula drain could contaminate neighboring wound resulting in wound infection. Finally, in case of wound problem such as wound dehiscence, frequent wound dressing causes unnecessary changes of skin barrier for pouching and subsequent problems: physical damage to skin, pain, and extra-cost. In order to resolve these difficulties, a new innovative method was developed and has been used to separate wound from ostomy/fistula. This method is named as the KHP-wing, where one edge of a piece of clear vinyl is fixed to skin between wound and ostomy/fistula using hydrocolloid and the rest leaf can provide more surface for pouching and wound dressing in the shape of a wing. To evaluate the effectiveness of the KHP-wing method, WOCNs are applying this method to patients with a wound and an adjacent ostomy/fistula. OUTCOMES: The study is in progress but close to completion. According to data collected until now, the following are expected: (1) it helps wound healing by preventing wound from contamination, (2) it reduces the frequency of dressing by protecting a wound against contamination from ostomy/fistula, and (3) wound dressing and ostomy/fistula pouching can be performed independently. FINANCIAL ASSISTANCE/DISCLOSURE: No financial assistance was received for this study. All are directly supported by Samsung Medical Center.
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PUSHING THE LIMITS: DEVELOPING EVIDENCE-BASED GUIDELINES IN PEDIATRIC WOC NURSING Karine Dupuis, MN, RN, ET, karine.dupuis@sickkids.ca, The Hospital for Sick Children, Toronto, ON
BACKGROUND/PROBLEMS: Pediatric enterostomal therapists (ETs) represent a small group of clinicians in Canada with a unique set of skills and expertise. Discussions between these individuals have revealed that minimal evidence-based guidelines exist in most pediatric settings across Canada in the areas of wound, ostomy, and continence nursing (WOCN). In an era where evidence-based practice is the ultimate goal in healthcare, one can quickly feel overwhelmed when practicing in a field such as pediatric WOC nursing. Unfortunately, most interventions and products in pediatrics either have not been well researched or have been adapted from ones more appropriate for adults. In order to address the issue of guidelines development, the clinical nurse specialist/ET nurse at a pediatric centre in Toronto has elicited the participation of ETs from various pediatric institutions across Canada. PURPOSE/OBJECTIVES: The purpose of this task force is to develop evidence-based guidelines pertaining to pediatric WOC nursing. The clinicians will create a framework to ensure a consistent and rigorous approach among all the contributing individuals. The panel of experts will then identify and prioritize specific clinical conditions in need of practice-guidelines development. OUTCOMES: In the short-term, the clinicians will focus their efforts on writing 3 guidelines. The guidelines will promote positive patient outcomes by ensuring appropriate use of wound and ostomy products, promoting preventive and early interventions and following important principles of wound management. The concerted efforts of skillful and knowledgeable ET nurses will also result in less tangible outcomes such as increased motivation and knowledge. CONCLUSION: This presentation will focus on the development of guidelines by pediatric ETs in Canada. Implementation will be the next phase of this project and is beyond the scope of this presentation. The author will conclude by discussing relevant factors such as resources, organizational and administrative support.
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ACHIEVING SUSTAINED POSITIVE OUTCOMES FOR PRESSURE ULCERS IN A HOSPITAL: A THREE-YEAR STUDY EVALUATING SKIN CARE CONTAINMENT AND PRESSURE ULCER INCIDENCE RATE Janice Alexander, RN, CWS, jbalex@hotmail.com, and Lison Plante, MSN, FNP, CWS, Crittenden Hospital, West Memphis, Ark
STATEMENT OF THE PROBLEM: Nosocomial pressure ulcers in hospitals are one indicator for quality of care and pose a significant public health problem, with the incidence rate ranging from <1% to 38% in the acute setting. Allman (1999) stated that pressure ulcers are associated with significant increases in hospital costs and length of stay. Conservative cost estimates of caring for a patient with a pressure ulcer may range from $500 to $50,000. A preventive care program can reduce the total healthcare costs, especially when compared with the increased cost of treating complications related to skin breakdown. PURPOSE: The purpose of this study was to evaluate the effectiveness of a program designed to improve clinical and cost outcomes by decreasing nosocomial pressure ulcers and optimizing cost containment of skin care products. METHODOLOGY: Crittenden Hospital is a 98-bed acute care facility. Baseline data for prevalence and incidence rate were collected and then documented monthly for a period of 3 years. The program included new protocols and education. RESULTS: Compared to baseline data, a reduction in the incidence rate was shown followed with a sustained low pressure ulcer incidence of <2.8%; additionally, a sustained cost containment for skin care products were documented during this 3-year study. CONCLUSION: Implementation of a consistent skin care protocols associated with education has demonstrated a sustained low incidence rate, a sustained cost containment for skin care products, along with staff satisfaction as the program gave them the ability to make a difference and improve patient care.
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SYNERGY OF LYMPHEDEMA MANAGEMENT AND SKIN/ WOUND CARE Andrea F. Brennan, OTR/L#55, CLT-LANA, DAPWCA, abrennan@ abrazohealth.com, Phoenix Baptist Hospital, Phoenix, Ariz
TOPIC: Synergy of lymphedema management and skin/wound care. PURPOSE: Clinical manifestation of mechanical failure of lymphatic system to transport protein-rich interstitial fluid out of tissue is an old concept when describing the etiology of lymphedema. Chronic degenerative and inflammatory process of skin, lymphatics, and lymph nodes with fibrotic change during episode of dermatolymphoadenitis is the new concept. It is not a simple phenomenon of accumulation of fluid, which causes swelling. Careful skin hygiene is a critical element of successful lymphedema therapy. OBJECTIVE: Lymphedema frequently occurs years after the initial insult to lymph vessels and lymph nodes following long interval of apparent well-being and normal functioning. It is often suspected by various factors for clinical manifestation (eg, trauma, infection, inflammation following minor skin injury, or insect bite). Skin problems usually cause a local high-protein edema that adds to the load of an already inadequate and overburdened lymphatic system and/or from phlebolymphedema due to the combined venous and lymphatic insufficiency. Considerable emphasis must be given to keeping the skin as healthy and supple as possible. In our clinic, The Phoenix Baptist Lymphedema Treatment Center in Phoenix, Arizona, we see problems that which arise or trophic skin changes that are already present. Methods have been utilized to deal with these lipodermatoscle-J WOCN ■ Volume 32/Number 3S Abstracts S17 rotic and lymphostatic dermatosis. OUTCOMES: Total care management is essential in treating the at risk lymphedematous limb. Complex decongestive therapy is an integral component to evacuate lymphostasis, which undermines the integrity of the skin and impedes wound healing. Skin and wound care is the first thing that must be completed, followed by manual lymph drainage and compression bandaging. Chronic wounds and severe skin alterations have been successfully managed with this intervention. CONCLUSION: Recognizing and adequately addressing lymphostasis will augment treatment. The integration of lymphedema management into comprehensive wound and skin care has shown success.
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CREATIVE USE OF BASIC DATABASE SOFTWARE TO PROMOTE COST-EFFECTIVE CARE, MONITOR OUTCOMES, AND MANAGE CLINIC OPERATIONS FOR WOUND CARE PROGRAMS Janell McNeill, MSN, CRRN, CWS, CWCN, janellmcn@comcast.net, Wound Healing Center at Kessler Memorial Hospital, Hammonton, NJ
PURPOSE: A basic computer database software program was instrumental in patient management for an outpatient wound care program. This freestanding information system required a reasonable initial financial investment by the hospital with minimal ongoing expense. It provided critical clinical information for the wound specialists to provide comprehensive wound care. OBJEC-TIVE: The management of a wound care patient can be a complex process with involved treatment follow-up and progress review to achieve healing outcomes. Wound specialists must provide timely, appropriate care in order to decrease length of stay and promote cost-effective treatment. As an outpatient wound care program expands, the wound care specialists need tools to assure comprehensive care management on a day-to-day basis. A database information management system is instrumental in tracking patient demographics, marketing details, day-to-day clinic operations, clinical outcomes and financial information of the wound care program. For this small rural hospital, the financial investment in such programs was cost-prohibitive. Purchasing a basic database program and investing in computer training for the director achieved a reasonable alternative. A wound care database was then designed to provide for the management of patient clinical information in this growing outpatient program. OUTCOMES: In the first year of use, 419 patients with 553 wounds were entered into the database. There were 121 different physicians referring 202 patients. Visit compliance was monitored weekly. Woundhealing outcomes (wounds healed during a timeframe) were calculated at 86.1%. The database is in its fourth year of use with 1400 patients and 3000 wounds now entered into the system at minimal financial reinvestment. CONCLUSION: The use of information systems can enhance the care management of patient with wounds. With a reasonable investment in basic computer training and purchase of common database software, a wound care program can readily monitor outcomes, patient care and overall program operations.
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PATHWAY TO PREVENTION OF PRESSURE ULCERS: AN INTERDISCIPLINARY APPROACH FOR LONG-TERM CARE Catherine Slocum, MS, FNP, cslocum@lourdes.com; Jacqueline Otremba, BS, RN; and Janine Savage, RN, United Methodist HomesHilltop Campus, James G. Johnston Memorial Nursing Home, Johnson City, NY
PURPOSE: A 4-pronged approach to pressure ulcer prevention in the long-term care facility was implemented with the goals of identifying risk factors, implementing timely prevention interventions, increasing early identification of Stage I ulcers, and increasing interdisciplinary participation in the prevention program. This new approach included (1) resource allocation, (2) intensive education, (3) bathing assistants responsible for weekly skin inspection, and (4) an interdisciplinary skin care team. OBJECTIVE: Consumers and regulatory agencies have high expectations for pressure ulcer prevention. While prevention has traditionally been seen as a "nursing" responsibility, an interdisciplinary approach is now the standard of care. At James G. Johnston Memorial Nursing Home, a 120-bed SNF in Johnson City, NY, barriers, including perceived lack of staff time, varying knowledge levels of staff, a framework of care with multiple caregivers, and interdisciplinary "turf issues," had to be overcome to achieve success in pressure ulcer prevention. OUTCOMES: In June 2000, the facility received a G-level "actual harm" deficiency in pressure sores during its annual Medicare/Medicaid survey, due to failure to adequately assess risk, identify early signs of ulcer development, and implement prevention interventions. Since the new prevention program was implemented, the facility has not received a deficiency in pressure ulcers. Prior to implementation, the pressure ulcer prevalence rate averaged 10.9%. Following implementation, the rate increased to 14.8%, which was expected and attributed to improved early recognition of Stage I pressure ulcers. Current prevalence rates have decreased to an average of 9.6%. CONCLU-SION: Through a comprehensive and innovative approach, the interdisciplinary team improved pressure ulcer prevention, which has resulted in improved quality of care and quality of life for its residents. FINANCIAL ASSISTANCE AND DISCLOSURE: Implementation required an investment of staff time, equipment, and supplies, all directly supported by United Methodist HomesHilltop Campus, James G. Johnston Memorial Nursing Home. Kathy Oden, BSN, RN, CWOCN, keoden@sentara.com; Corrine Alvey, BSN, RN, CWOCN; and Deborah Hartz, MA, RN, CDE, Sentara Norfolk General Hospital, Norfolk, Va PURPOSE: To reduce the number of hospital acquired stage 3 and 4 pressure ulcers while maximizing the wound ostomy & continence (WOC) nurses' time. OBJECTIVE: The rate of full-thickness hospital-acquired pressure ulcers at our 569-bed tertiary hospital increased 100% from CY2002 to CY2003. Despite an existing skin care program, a new pressure ulcer prevention (PUP) program was needed. PROGRAM OBJECTIVES: Reduce the number of hospitalacquired full-thickness pressure ulcers without decreasing WOC nurse time from clinical duties, maximize the education/resources of clinical staff, and obtain management support. METHOD: Numerous interventions were initiated, including development of quarterly education programs for nursing care partners, monthly newsletters and "lunch and learn" sessions focusing on specific aspects of skin care; pocket cards with prevention strategies and treatment plans for all clinical staff, promotion of regular "multidisciplinary skin rounds" aided by computer generated "skin score reports," twice-a-day "skin scores" on all patients with the implementation of "skin care protocol" if the score reached a specific level. Administration supported all interventions employed. OUTCOMES: There has been over a 75% decrease in the number of full-thickness hospital-acquired pressure ulcers without an increase in the number of full-time WOC nurse positions. CON-CLUSION: In addition to reducing the number of stage 3 and 2835-02_WJ3203-Abst-newrev.qxd 05/04/05 12:47 Page S17 S18 Abstracts J WOCN ■ May/June 2005 4 pressure ulcers, the PUP program created a "Triangle Approach" to share the management of high-risk patients, thus maximizing the WOC nurses' time. The "Triangle Approach" focuses on the patient being supported by the triangle points of management, multidisciplinary, and bedside teams. FINANCIAL ASSISTANCE/ DISCLOSURE: Development, production, and dissemination of all educational materials and implementation of the PUP program required an investment of time from clinical staff, the WOCs, and the education department, all directly supported by the Sentara Hospital System.
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THE UNIVERSITY OF TEXAS M.D. ANDERSON CANCER CENTER WOUND OSTOMY CONTINENCE NURSES: PROMOTING A POSITIVE IMAGE OF NURSING IN THE INSTITUTION AND THE COMMUNITY C. C. Monge, DABFN, CWOCN, ccmonge@mdanderson.org, University of Texas M.D. Anderson Cancer Center, Houston, Tex
ABSTRACT This poster will showcase, through photographs and examples of promotional materials, the various way in which the wound ostomy continence nurses at The University of Texas M.D. Anderson Cancer Center promote nursing, and specifically wound ostomy continence nursing, at M.D. Anderson Cancer Center and in the Community*. Our promotional activities during the past year included an in-house publication to highlight wound ostomy continence nursing; a poster displayed throughout the hospital that illustrates the wound ostomy continence nursing specialty; the distribution of prevalence studies spearheaded by the wound ostomy continence nurses at M.D. Anderson; inservice training on skin, wound, and ostomy nursing for the student nurses and registered nurses employed at M.D. Anderson; lectures and precepting in our service line to students at the University of Texas M.D. Anderson Wound Ostomy Continence Nursing Education Program (1 of 3 full-scope programs in the nation); lectures on our field of expertise to student nurses at all local universities; presentations to junior high school students in the community promoting nursing as a career with an emphasis on wound ostomy continence nursing; and nomination of a wound ostomy continence nurse for the Annual Outstanding Oncology Award at M.D. Anderson Cancer Center (our nominee is the first WOCN to ever win the award). The reality of nurses and of the nursing profession is much more than the image portrayed in the media. Among the challenges facing today's professional nurse are promoting the profession in a positive light and focusing on strategies that will move the profession forward in the new century. *COMMUNITY: Texas Medical Center, the City of Houston, the State of Texas, the United States, the World. Becky Strilko, RN, CWOCN, BeckyLStrilko@ProvenaHealth.com; Judith Morey, RN, CWOCN; and Alison Barna, MSN, RN, CWOCN, Provena St. Joseph Medical Center, Joliet, Ill PURPOSE: The standard foam mattresses in our facility needed to be replaced on all medical-surgical units due to wear and tear. Along with rising costs in specialty bed rentals and concern over nosocomial pressure ulcers, our hospital opted to purchase pressure relief mattresses to replace the old foam mattresses. After clinical evaluation of several dynamic pressure relief mattresses, both powered and nonpowered, we chose a mattress designed with a newer technology of atmospheric air. Excluding the ICU's, our facility was 90% converted to non-powered and will be 100% converted in 2005. SETTING/SUBJECTS: A 350-bed hospital with an average of 253 patients assessed at time of pressure ulcer prevalence studies. METHODOLOGY: The new pressure-relief mattresses were placed on the medical-surgical beds in January 2004. A comparative percentage of patients with facility-acquired pressure ulcers (12.4%) were obtained from pressure ulcer prevalence study data last performed in March 2003. A repeat prevalence study was performed 3 months post-new mattress application in April 2004 with 255 patients' assessed. The data revealed a 9% rate of patient's with facility-acquired pressure ulcers. This study was again repeated in August 2004 with 251 patients assessed revealing a rate of 4.78%. CONCLUSION: With the replacement of the standard foam mattress to the nonpowered dynamic surface, we were able to decrease our facility-acquired pressure ulcers by 61.5% over a 8-month time period. Quarterly pressure ulcer prevalence studies will continue to be performed to evaluate the effectiveness of the mattress. FINANCIAL ASSISTANCE/DISCLOSURE: No financial assistance was received for the study. Poster development/ registration and travel to be provided by BG Industries. (NPUAP, 2001 ). This project was developed in an attempt to facilitate a support surface trial by developing an objective clinicalevidence perspective for evaluation of support surfaces. METHOD-OLOGY: Evaluation forms were developed. Three support surfaces and companies were included in the trial. Decision tables were developed based on categories included on the evaluation form (clinical evidence, service, clinical outcomes, nurse satisfaction, weight limits, and warranty). Each category was weighted according to the importance of the category by clinicians. Percentage scores were assigned to each category and tabulated. RESULTS: The decision matrices provided information and evaluation data in a consistent manner resulting in total nonbiased scores for products A, B, and C. Based on theses results, a support surface was recommended for purchase. CONCLUSION: The decision matrices process assisted the team in evaluating 3 support surfaces. Evidence was transferred into numeric values, and differences in support surfaces were demonstrated in graph format. This allowed for a less complicated and more objective procedure for comparison of differences in product performance. This method was helpful in standardizing the selection and procurement of support surfaces. J WOCN ■ Volume 32/Number 3S Abstracts S19
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EFFECTS OF A NONPOWERED DYNAMIC SURFACE ON REDUCING FACILITY-ACQUIRED PRESSURE ULCERS
654
DEVELOPMENT OF A STANDARDIZED, OBJECTIVE SUPPORT SURFACE EVALUATION PROCESS
The literature suggests that digestive enzymes, along with the caustic and alkaline fluids they are contained in, play a major role in skin breakdown when they come into contact with the skin. These digestive enzymes are found in all secretions associated with the alimentary canal, which include stool and gastric fluids. The purpose of this study is to evaluate the in vitro functionality of a new formulation with respect to its enzyme inhibition properties. In order to evaluate the efficacy of this new formulation, it was necessary to develop and validate an analytical procedure adequate of providing reproducible data on the effects of this formulation on 2 key digestive enzymes, trypsin and lipase. TRYPSIN INHIBITION: Initial absorbance values lower than the control value indicate less substrate breakdown, therefore, a greater protease inhibitor activity for the pre-back digestion samples. Higher measurements mean that there was more substrate available after the initial digest post-back digestion samples. This indicates that the inhibitors tested were able to decrease the activity of trypsin. In the oil-in-water base (lotion), values higher than the control also indicate that there was inhibition of trypsin activity. It seems that INHIBITOR A and INHIBITOR B lotions were both able to inhibit trypsin when formulated into a lotion; however, INHIBITOR A was somewhat better at inhibiting trypsin activity. The digestive enzyme inhibitors found in both the INHIBITOR A and INHIBITOR B lotions seem to inhibit lipase activity, as well. However, the INHIBITOR A lotion proved to be a more effective lipase inhibitor than the INHIBITOR B lotion.
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PREVENTION OF SKIN BREAKDOWN IN THE CHRONIC RENAL PATIENT ON HAEMODIALYSIS Jimmie-Lou Ault, CWOCN, jault@crh.org, and Lena McCubbin, CNS, CWOCN, Columbus Regional Hospital, Columbus, Ind
Hemodialysis treatment requires long hours of immobility. Without early intervention, the authors hypothesize that the chronicity of this immobility, combined with comorbidities, greatly increase the risk of skin breakdown in the chronic renal patient (CRP). With this in mind, our purpose is to develop and implement an early intervention skin care program for the prevention and treatment of skin breakdown in the hemodialysis patient. Instead of depending upon the judgment of the caregiver, standing orders were developed to provide specific standards that are implemented upon the admission of the CRP to acute care that extend across the continuum of care. Our objective was to implement a "door" to discharge preventative and treatment skin care program, which includes postdischarge. The patient and/or significant other are taught to expect and advocate for this level of care. It is the authors' belief that early intervention by the certified WOC nurse will reduce pressure ulcer occurrence, improve existing shear/pressure related wounds, prevent perianal skin breakdown, and treat yeast in its early stages in this targeted population. Two renal specialists and a vascular surgeon were identified as physician champions. Specific staff was targeted for education. The education plan included poster presentations, unit meeting inservices, and mini-inservices at change of shifts. Oneon-one meetings were scheduled with key department heads. The WOCN meets with each patient and/or significant other for education. OUTCOME MEASUREMENT: A focus study is underway. This study includes data collected on the initial admission, at discharge, and any readmission. The PUSH Tool (pressure ulcer), Square Surface Score (moisture breakdown and yeast involvement), and Lickert Scale (health beliefs) are used to evaluate patient outcomes. These data will be compiled and analyzed. No financial support was received for this study. Barbara J. Hiser, MBA-HA, RNBC, Barbara.Hiser@health-first.org; Jana Rochette, BSN, RN, CWOCN; Shawna Philbin, BSN, RN, CWOCN; Nancy Lowerhouse, BSN, RN, CWOCN; and Catherine TerBurgh, MEd, MSN, FNP, Holmes Regional Medical Center, Melbourne, Fla PURPOSE: A pressure ulcer prevention program involving a team approach to patient management that changed the role of the WOCN from a "dressing changer" to a "team leader and educator" was applied to a facility with a high incidence of pressure ulcers, yielding significant patient and financial benefits. OBJEC-TIVE: Hospitals in the United States are increasingly concerned in reducing the number of hospital acquired pressure ulcers (APUs). Unfortunately, APUs have increased at a national level from 7.1% (1999) to 7.7% (2004) (Cuttino, 2004) . In order to impact our facility's overall rate of 9.5% in 2003, a process improvement and education program was begun. OUTCOMES: Quarterly pressure ulcer prevalence studies were initiated. The MICU, with a cumulative average of 29.6%, had the highest prevalence of acquired pressure ulcers. Significant structural and process changes were made, and ongoing, multilevel education was performed (including physicians). Resources were added, such as the purchase of the TotalCare SpORT bed systems, which provided an excellent treatment surface upon admission. Following implementation, a decrease from 29.6% in the MICU to quarterly prevalence rates of 4%, 0%, 0%, and 0% for the 4 quarters ending June 2004 were seen. In the last 2 years, our annual average MICU admission was 860 patients. At 29.6%, 255 patients annually would have acquired pressure ulcers. If even a 1 less day of ICU LOS was achieved, a minimum of $255,000 annual cost reduction could be seen. CON-CLUSION: The continuing process improvement program has significantly impacted our rate of APUs. Attitudes have changed from thinking that pressure ulcers are inevitable, to believing that they are preventable. WOCN's are now seen as resources and clinical experts. Financial resource utilization and overall quality of care has also drastically improved. Siva Narayanan, MS, MHS, siva_narayanan@beverlycorp.com; John Van Vleet, MD; and Robert N. Ross, PhD, Beverly Enterprises, Inc., Fort Smith, Ark PURPOSE: The purpose of this retrospective observational study was to compare outcomes (progression, healing rate, time to heal) and nursing labor costs associated with use of topical treatments and dressings for pressure ulcer (PU) among residents in skilled nursing facilities (SNF Terry Hargraves, RN, II, terry.hargraves@health-first.org; Frances Hannum, RNC, Manager; and Catherine TerBurgh, MEd, MSN, FNP, Holmes Regional Medical Center, Melbourne, Fla PROBLEM: At our Magnet designated hospital, participation in a national study revealed an opportunity existed to reduce the incidence of 7 East-acquired pressure ulcers. Studies show patients with facility-acquired pressure ulcers have an increased length of stay and increased cost of treatment. Research indicates pressure ulcers usually occur in patients with predisposing risk factors. Our unit consists of geriatric patients with many co-morbid conditions. METHOD: Once patients are identified, prevention can be started early to reduce the risk of pressure ulcers developing. Our unit's action plan included the implementation of weekly skin rounds with bedside education for staff, in-services, skills fair, the opportunity to trial risk assessment tools and prevention products, CEUs on skin assessment, nutritional consults, review of clinical charting and documentation with feedback to staff, incorporation of skin rounds into staff meeting and unit news, utilization of unitbased skin resource nurse. An interdisciplinary team was formed to revise our current computerized documentation. RESULTS: NDNQI Pressure Ulcer Prevalence Study revealed a significant decrease in 7 East-acquired pressure ulcers. A data abstraction report was created for staff to easily identify patients at risk. Biweekly interdisciplinary team rounds include risk assessment and prevention. Shift report includes skin assessment and prevention in place. Revisions to policies and procedures were implemented. CONCLUSION: When staff have education, the appropriate tools, designated resource nurse and supportive manager, and buy in, positive results can be measured! (Early identification + prevention = decreased incidence.) Kathleen M. Buckley, PhD, RN, buckleyk@cua.edu, and Linda Koch Adelson, BSN, RN, CWOCN, Catholic University of America School of Nursing, Washington, DC PROBLEM: Wounds account for 31% to 36% of patients in home care with approximately half of these patients having more than one wound. Home health nurses are able to provide a higher level of quality care in managing complex wounds when the consulting services of a certified wound specialist are available. Unfortunately, skilled home care under the supervision of a certified wound specialist is often expensive and unavailable. Since many of the components of wound assessment are visual in nature, wound consultations may be expanded by using digital images. However, there are limited resources available for the education and training of home care nurses to acquire images that are reliable and accurate. OJBECTIVE: The authors' goal was to develop a competency-based learning program, which covered the primary elements of wound photography for home care nurses at Adventist Home Health (AHH) in the Washington, DC, metropolitan area. OUTCOMES: Some the issues that arose in the development of this competency included patient confidentiality, camera technique, infection control, and the accompanying nursing assessment. CONCLUSIONS: In addition to using digital images for consultation, wound images have the potential for improving the standard of wound care by providing a permanent record of the wound condition at baseline and at recurrent intervals, documenting wound findings for case reviews, acquiring and retaining services and reimbursement, educating health professionals, functioning as motivational tools for patients who are not able to directly visualize a wound, and in supporting treatment plans should legal issues arise. FINANCIAL ASSISTANCE/DISCLOSURE: No financial support was received for this project.
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A WOCN TEAM APPROACH TO REDUCING WOUND CARE COST M. RAY JUSTICE, BSN, RN, CWOCN, ray.justice@nmhs.net, North Mississippi Medical Center Home Health, Tupelo, Miss
PURPOSE: A new wound care treatment guide for complex wounds was implemented by the WOCN team of 5 nurses to reduce the cost of treating the home health patients with wounds. A printed guide with identifying wound categories with photographs and evidence-based treatment guides that varies depending upon amount of wound exudate was developed by the WOCN team and our primary wound product provider to educate the HH agency's staff nurses. OBJECTIVE: NMMC HH had hired a new director in February 2004. At this time the, home health was involved in implementing a new data system, and had a projected loss of over $3 million by the end of the fiscal year of September 30, 2004. NMMC HH serves patients in a 17 county area of northeast Mississippi and has a population of 2300. A total of 72% of this 2300 population has wounds that require treatment. The cost of wound patients with a loss of over 5% for October 2003 was 3.76% and the monthly allowance was $226,970. The new director met with the WOCN team in April and gave the team a goal of reducing these wound care costs by 40% by September 30. OUTCOMES: The team with the help of our product provider developed the evidence based wound treatment guide and inserviced all of the HH staff nurse by the end of June, 2004. At the end of September 30, 2004, the monthly allowance was $83,760 and the over $5000 loss was reduced to 1.2%. This WOCN team significantly affected the operating expenses for our wound patient population by achieving the goal of 40% reduction in cost, and contributed to the agency overcoming the loss and ending the fiscal year with a profit margin. David Brett, MS, BS, dave.brett@smith-nephew.com, Smith & Nephew, Wound Management Division, Largo, Fla The purpose of this report is to document a series of in vivo subjective performance evaluations (n = 90+) performed over a period 2835-02_WJ3203-Abst-newrev.qxd 05/04/05 12:47 Page S20 J WOCN ■ Volume 32/Number 3S Abstracts S21 of 30 days on a new papain-urea-chlorophyllin enzymatic debridement formulation topically applied to a variety of wound types. Evaluations were performed by practicing clinicians with feedback obtained via a qualitative interview/survey. The goal of the interview/survey was to gain unbiased feedback on topics such as ease of use, efficacy, side effects, etc., of the formulations in use. The questions were objective and open ended, with the intent of soliciting honest/unbiased feedback. No leading questions were permitted. As information on the performance and efficacy was the goal of this exercise, no promotional or sales activity was permitted. The debriding agent was assessed by the clinician for a period of 30 days, with weekly interim updates. Trends for each of the 10 questions asked are summarized in the conclusion section. From this evaluation it is apparent that some clinicians use the p-u-c formulations after some other type of agent or mode of debridement has been used while others use these formulations from start to finish (closure). All clinicians interviewed use these formulations until the wound is closed. All clinicians interviewed used these formulations on various types of slough; however, some clinicians do not use this type of formulation on eschar. The wound types treated w/this formulation were PU, VLU, AU, and DU (all types). The comments on product performance were extremely positive for the most part w/only a single clinician preferring the ease of use of other formulations over the new formulation. However, all clinicians felt the new formulation was equally efficacious to others. Several clinicians due to the lack of pain experienced w/the new formulation felt it offered an advantage over other similar formulations. Jean M. Stow, MSN, RN, CNS, CWOCN, Jean_Stow@MHHS.org, Memorial Hermann Northwest Hospital, Houston, Tex PURPOSE: Pressure ulcer prevention and related product cost containment across the continuum of care are ongoing challenges for healthcare providers. In March 2003, a prevalence and incidence study was done in our 200-bed acute care hospital and in the 19-bed rehabilitation unit. It identified an incidence rate of 17% and 33%, respectively. Financial reports revealed a yearly expenditure of $78,209 for specialty bed rental. These results were despite existing skin care/specialty bed-rental protocols. The purpose of our practice innovation was to assess/modify existing protocols and clinical practice to decrease pressure ulcer incidence rate and specialty bed rental dollars throughout our facility. OBJECTIVE: The objectives of this practice innovation were to reduce the pressure ulcer incidence while reducing specialty bed rental dollars across the continuum of care. The current protocols were evaluated and revised, emphasizing prevention and early intervention strategies such as the use of static air technology. Clinical education was provided to licensed and nonlicensed personnel by a CWOCN with emphasis on prevention strategies. The product vendors offered objective-based product education to enhance selection competence by the staff. Finally, a comprehensive weekly skin audit program was initiated on the medical-surgical, intensive care, and rehabilitation units. OUTCOME: In March 2004, a follow-up prevalence and incidence study identified an incidence rate of 7% for acute care and 0 % for rehabilitation. This was a 59% and 100% reduction, respectively, from the previous year. Simultaneously the specialty bed rental expenditures decreased to $40,014, a 49% reduction. This practice innovation has been successful in reducing the pressure ulcer incidence rate as well as specialty bed rental costs across the Continuum of Care. It also served to remind us of the importance of conducting ongoing evaluations of protocols so that they will continue to promote cost containment and most importantly optimal patient outcomes. Rebecca Eichler, BS, RN, ET, CWOCN, reichler@lakelandregional.org, and LeeAnn Maki, BS, RN, ET, CWOCN, Lakeland Health & Healing-Home Care Division, St. Joseph, Mich PURPOSE: To describe a protocol for our homecare agency which validates use of a hydrogel with a 72-hour wear time to decrease daily or twice daily dressing changes to three times a week for selected patient situations. OBJECTIVE: Changes in payment due to the Perspective Payment System (PPS) in the homecare setting has made it so homecare agencies can no longer afford to send skilled nurses to complete daily or twice daily dressing changes. Our ET/CWOCN homecare practice encompasses a diverse population, and frequently we were unable to shift wound care responsibilities from skilled nursing to the patient/family. A protocol that is user friendly and cost effective was needed to reduce skilled nursing visits while promoting optimal wound healing outcomes. OUTCOME: The presentation will cover the details of the protocol, its implementation, and evaluation. The impact of the protocol will be illustrated in one or more case studies. The product of interest was a hydrogel wound dressing that promotes (1) a moist wound environment, (2) autolytic debridement, (3) granulation of the wound bed, and (4) epithelialization. The outcomes of interest are ease of use and required frequency of dressing changes. CONCLUSION: Implementing a hydrogel wound dressing protocol with simple easy steps helped us to foster family involvement with wound care. By decreasing skilled nursing visits and quantity of supplies, 3-times-per-week dressing changes lowered overall wound care costs with positive wound healing results. FINANCIAL ASSISTANCE/DISCLOSURE: The support of Hollister Incorporated for this project is gratefully acknowledged. Mary Jo Beneke, BS, RN, CWOCN, mbeneke@yumaregional.org, and Josephine Doner, BSN, RN, MA, CIC, Yuma Regional Medical Center, Yuma, Ariz TOPIC: According to the Centers for Disease Control and Prevention (CDC), 2.7% of surgical procedures are complicated by nosocomial surgical-site infections (SSIs), resulting in increased morbidity, hospitalization, and costs. OBJECTIVE: To evaluate whether the use of antimicrobial gauze dressings would contribute towards a reduction of nosocomial SSI rates. METHODOLOGY: This was a 6-month surveillance study to track the incidence of nosocomial SSIs within an acute care setting. This study was designed to exchange, hospital-wide, the supply of nonantimicrobial gauze dressings for gauze dressings that contain an antimicrobial agent. As this action did not interfere with current wound care protocol, institutional staff did not require inservicing regarding the dressings' use. With the exception of the surgical service, none of the staff were alerted to the switch to the antimicrobial dressings; due to a similar label and product appearance, the dressings' packaging assisted in preserving this blind. Already in charge of tracking nosocomial SSIs, Infection Control continued this pro-S22 Abstracts J WOCN ■ May/June 2005 tocol by collecting prospective data of SSI incidence rates from study initiation to 6-months. These data were compared to the historical control of SSIs occurring during the same time period of the previous year. RESULTS: During the 6-month study duration, nosocomial SSIs decreased by 57% (12 infections) as compared to the historical control. Using attributable costs to treat a SSI ($15,646) , this calculates to a savings of $187,752 for the hospital. CONCLUSION: By simply exchanging nonantimicrobial gauze dressings for antimicrobial gauze dressings, this facility was able to help reduce nosocomial SSIs, thus creating improved outcomes for the surgical patient and cost savings for the hospital. Christine Barkauskas, BA, RN, CWOCN, APN , cbarkauskas@ silvercross.org; Linda Galvan, BSN, RN, CWOCN, APN; and Andrea McIntosh, BSN, RN, CWOCN, APN, Silver Cross Hospital, Joliet, Ill PURPOSE: To document the efficacy of Silver Foam dressings* in the treatment of colonized wounds and wounds that are at risk for infection. OBJECTIVE: Until recently, the use of antimicrobial creams and ointments BID or TID was the treatment of choice for colonized and/or infected wounds. Due to the overuse of antibiotics, resistant organisms have developed necessitating alternate methods of treatment. Now, multiple dressings containing silver are available, which decrease the frequency of dressing changes and deliver broad-spectrum antimicrobial action. An additional benefit of topical Silver is the sustained-release of ionic silver and that it rarely induces bacterial resistance. OUTCOME: We hypothesize that the new Silver Foam Dressing* will improve wound healing outcomes and be more user friendly and cost effective. Joan A. McInerney, MSN, RN, BC, CWOCN, joanmcinerney@ earthlink.net, and Sandra K. Wheeler, BSN, RN, CWOCN, NCH Healthcare System, Naples, Fla PURPOSE: A new system was created to decrease the prevalence of hospital-acquired heel pressure ulcers through early identification of patients at particular risk and quick implementation of protective measures. OBJECTIVE: From June 2000 through July 2003 pressure ulcer prevalence surveys were conducted every 6 months at this 500-bed 2-hospital system. Heel ulcers usually accounted for more than half of our hospital-acquired prevalence rate. Our July 2003 survey showed a hospital-acquired heel ulcer rate of 3.2%. A Task Force was convened consisting of the risk manager, critical care physician, podiatrist, clinical informatics analyst, chief medical officer, chief nursing officer, managers of central distribution, education, or services and critical care, as well as the 2 WOC Nurses. The task force recommended using a new, pressurerelieving boot on all ventilated patients and those with a diagnosis of end-stage renal disease. Because we have an electronic medical record, the IT department was able to link an automatic order for the boots and a consult to the WOC nurses to any order for a ventilator or hemodialysis. The boots were immediately sent to the patient's location. The WOC nurses monitored compliance with the boots' use. OUTCOME: Our next prevalence rounds in January 2004 showed our hospital-acquired heel pressure ulcer rate was down to 1.9%. In July 2004, the heel ulcer rate was 1.3%. Heel pressure ulcers now only accounted for 25% of all hospitalacquired pressure ulcers. CONCLUSION: The automatic orders for boots and consult to the WOC nurses for two groups of patients who are at risk for developing pressure ulcers dramatically reduced the prevalence of hospital-acquired heel pressure ulcers in our hospitals. FINANCIAL ASSISTANCE DISCLOSURE: The support of DM Systems, Inc., makers of the HEELIFT in the production of this poster is gratefully acknowledged. Denise Elber, RN, CWOCN, elberd@slrmc.org, St. Luke's Regional Medical Center/Mountain States Tumor Institute, Boise, Idaho The Idaho Elks Wound Clinic in Boise, Idaho, has been successfully managing most lower extremity edema with the use of tubular elastic bandages (TEB). The cornerstone or gold standard for venous ulcer management is edema reduction. Literature suggests graduated compression of 20-40 mm Hg (after assessment) is therapeutic in prevention and treatment of venous ulcers. Although TEB is typically recommended for general edema management, many of our patients have responded well when this product has been utilized in the management of lower extremity wounds when the patient either rejects or is unable to tolerate standard compression therapy. The level of compression is dependent upon limb circumference, whether a single-layer or double-layer or combinations of lengths are applied. Our patient's ability to comply and accept a wound protocol of care is related to ease of application, low-cost, and comfort. Therefore, TEB has helped improve our wound healing results for the patients who cannot tolerate or are otherwise noncompliant with other forms of compression. Clinic staff highlight advantages of TEB in management of mixed disease. The patients are able to don TEB in acute conditions where more compression may increase inflammation. It is also easy for any level of care-provider to fit and apply. It has the ability to provide a wide range of compression and it is an excellent choice for initial compression to check tolerance. Some disadvantages include that it is not as effective in management of well-established brawny edema and that it is not latex-free. Some of the patients choose to continue to use TEB post-healing for long-term management. Future study is planned to measure TCPO2 and TEB utilization. David W. Brett, MS, BS, dave.brett@smith-nephew.com, Smith & Nephew, Wound Management Division, Largo, Fla Rheology is the science of the deformation and flow of materials in terms of stress, strain, and time. In this study, oscillation and flow experiments were conducted to determine the rheological profiles of the various formulations. In use, these profiles give insight into the "spreadability" and stability of the various formulations. The "spreadability" gives an indication of how easily the formulation will spread on the wound and may have implications as to how well the formulation will stay in the wound, delivering its active components. Stability gives insight into the shelf life and efficacy over time. Another experiment performed in the oscillatory mode is a frequency sweep. This experiment gives precise data on when an emulsion is likely to destabilize. Stability of an emulsion is key to the shelf life and performance of the product. As the emulsion destabilizes (over time), the viscous character of the emulsion exceeds the elastic character. As this occurs, the oil and water phases of the emulsion start to separate. When this occurs, the formulation is no longer homogeneous, and its efficacy and function can be altered. As the viscous character overtakes the elastic character of the emulsion (typically at lower frequencies), the value of tan delta increases. At the point where this value increase above 1, phase separation within the emulsion is starting to occur and it is destabilizing. As lower frequencies represent stress over a longer period of time, a frequency sweep can be used to gain insight into the potential shelf life of a given emulsion. To evaluate the rheological characteristics of samples during this investigation, a CarriMedcontrolled stress rheometer was used. Employing a cone and plate geometry with a 55 µm truncation, it was possible to get accurate repeatable data for both oscillation and flow experiments. Vivian S. Sternweiler, MS, RN, CWCN, vsternweiler@nesinai.org, New England Sinai Hospital and Rehabilitation Center, Stoughton, Mass Hospitalized patients with pressure ulcers or who are at high risk for pressure ulcer development may also be at high risk to fall. In today's hospital environment, the use of physical restraint to prevent patient falls has been replaced by the use of low-to-the-floor beds. These beds sit very close to the floor and have low-profile side rails to reduce the potential for injury if a patient falls out of bed. When a low air-loss replacement mattress with a 6-10" height is placed on this type of bed, the side rails are rendered useless since the height of the therapeutic replacement mattress exceeds the height of the side rails. Patients who are at risk to fall and require low air-loss therapy are being given the combination of a low-tothe-floor bed and a low air-loss mattress overlay. The low air-loss mattress overlay is traditionally used on top of a standard hospital mattress to offer the patient pressure reduction therapy. The overlay is made of multiple air "pillows" that are secured together to form a pressure-reducing surface. A 1-in-thick mat is placed under the low air-loss overlay, on the low-to-the-floor bed frame, to provide a stable surface in case the overlay deflates. The profile of the mat and the low air-loss overlay combined is only about 4 in high, allowing access to the side rails. For this unique population, the air mattress overlay will be used as a low air-loss mattress replacement system. Since the low-air-loss mattress overlay is able to accommodate patients with Stage I through Stage IV pressure ulcers when used on a standard hospital mattress, it is anticipated that it will perform in a similar manner when used as a mattress replacement and placed on a low-to-the-floor bed. Hyo Jeong Song, PhD, RN, hjsong@cheju.ac.kr, Department of Nursing, School of Medicine, Cheju National University, Jeju-shi, Jeju-do PURPOSE: To provide the basic data for the development of the management program for overactive bladder by ascertaining its prevalence among Korean women aged over 30 years and the factors related to its occurrence. METHODOLOGY: The study was performed by using self-questionnaires through the community-based cross sectional study from May to July 2000. The subjects consisted of 2869 women, aged over 30 up to 89 years, among those who understood and responded to the questionnaires, and was residing in Seoul, Kyongki Kangwon, Chungchong, YongNam, HoNam, Cheju provinces. They also did not have neurological problem and diabetes. The data were analyzed by Student t test, χ 2 test, and multiple logistic regression with using SAS program. RESULTS: Subjects experienced at least one of frequency, urgency, nocturia, urge incontinence for the past year, and 52.3% of the subjects had experienced symptoms at least once in 5 voidings. The highest prevalence of overactive bladder was 86.2 % in the category for 70 to 89 years, 74.3% for the 60s, 45.3% for the 40s, and 42.5% for the 30s. In the symptoms of 1499 women among subjects, 19.4% of them had nocturia, 18.2% frequency, 10.5% urgency, 9.6% urge incontinence, 9.5% frequency and urgency, 5.9% frequency and nocturia. The age (OR = 1.041, 95% CI = 1.027, 1.055) and the menopause (OR = 0.696, 95% CI = 0.527, 0.919) were related to overactive bladder occurrence. CONCLUSION: Findings indicated that about the half of the women aged over 30 years had symptoms for overactive bladder, and the prevalence was higher in old women and the women with menopause. So, the prevention and management programs for overactive bladder are required to be developed, and the primary screening programs based on community shall be developed. DISCLOSURE: No financial assistance was received for this study. Michaela H. Purcell, MSN, emeadows@lilly.com, Eli Lilly & Company, St. Louis, Mo PURPOSE/RATIONALE: To review the usefulness as well as disease specificity of questionnaires used in the evaluation of the female lower urinary tract. The process of scientific validation will be discussed and best practice recommendations will be offered to urological nurses in both the clinical and research settings. METHODS: A complete search of the scientific literature, from January 1994 through May 2004, was conducted. All urinary incontinence quality-of-life and symptom severity tools were reviewed in addition to current "validation and standardization" reports of the International Continence Society. RESULTS: Optimal evaluators of symptom severity include the Bristol Female Lower Urinary Tract Symptoms, Urogenital Distress Inventory, Urge Urinary Distress Inventory, and the Incontinence Severity Index. Recommended Quality-of-life tools are the Incontinence Quality of Life Questionnaire, Incontinence Impact Questionnaire, Urge Incontinence Impact Questionnaire, and the Kings Health Questionnaire. CONCLUSION: Many tools are available for use. Many are not intended to distinguish between different types of incontinence, underscoring the necessity of nursing expertise in assessing stress, urge, and mixed incontinence. Scientific validity and condition specificity are required for questionnaires to be useful in making key treatment decisions and outcomes measurements. IMPLICATION: The urological nurse must be selective in the choice of appropriate questionnaires used in both research and clinical practice. This choice directly influences credibility of re- John Cockwill, MSc, BSc (Hons), john.cockwill@smith-nephew.com, Smith and Nephew Inc., Largo, Fla The irritant potential of proteolytic and other digestive enzymes has been suggested as a contributing factor in infant diaper dermatitis (Anderson et al, 1994) . Fecal enzymes have been proposed as the etiologic element in diaper dermatitis by Buckingham et al (1986) and similarly, the digestive enzymes in feces have been reported to possess skin irritation potential by Berg (1988) . Digestive enzymes, along with caustic and alkaline fluids they are contained in, play a major role in skin breakdown when they come into contact with the skin. These digestive enzymes are found in all secretions associated with the alimentary canal, which include stool and gastric fluids. The contact of these fluids/feces with the skin not only leads to skin breakdown, but can also lead to infection, and an overall increase in treatment costs (Erwin-Toth, 1995) . Skin protectants provide a physical barrier between the skin and caustic bodily fluids (Fleck, 2004) . What is usually not known, however, is whether or not the skin care products are effective in the prevention of perineal dermatitis (Lyder, 1992 ). An OTC (drug) topical skin protectant for diaper dermatitis, patent pending, has been developed. The OTC Skin Protectant, which contains a proprietary composition of ingredients, is expected to neutralize the damaging effects of digestive enzymes, therefore helping to prevent diaper dermatitis. It is expected that the OTC Skin Protectant, will remain bound to the surface of the skin until exfoliation occurs, thus protecting the skin from acidic and alkaline pH fluids. The intention of this initial pilot study was to determine the safety and efficacy of the Skin Protectant after skin exposure to proteolytic enzymes on healthy volunteers. A full description of the objectives for the study, results, methodology, and conclusions will be presented in full, in the final poster presentation. Denise M. Elser, MD, emeadows@lilly.com; Gamal M. Ghoniem, MD, FACS; Jules Schagen Van Leeuwen, MD, PhD; Robert M. Freeman, MD; Yan D. Zhao, PhD; Ilker Yalcin, PhD; and Richard C. Bump, MD, Advocate Christ Medical Center, Oak Lawn, Ill PURPOSE: The primary aim was to compare the effectiveness of combined pelvic floor muscle training (PFMT) and duloxetine with imitation PFMT and placebo for 12 weeks in women with stress urinary incontinence (SUI). Secondary aims were to compare the effectiveness of combined treatment with single treatments, single treatments with each other, and single treatments with no treatment. METHODS: This blinded doubly-controlled randomized trial enrolled 201 women aged 18-75 years with SUI at 17 incontinence centers in the Netherlands, United Kingdom, and United States. Women averaged at least 2 incontinence episodes/day and were randomized to 1 of 4 combinations of duloxetine 80 mg/day, placebo, PFMT, and imitation PFMT, including combined treatment (n = 52), no active treatment (n = 47), PFMT only (n = 50), and duloxetine only (n = 52). The primary efficacy measure was incontinence episode frequency (IEF). Other efficacy variables included the number of continence pads used and the Incontinence Quality of Life (I-QOL) questionnaire score. RESULTS: The intent-to-treat population IEF analysis demonstrated the superiority of duloxetine, with or without PFMT, compared with either no treatment or with PFMT alone. However, both pad and I-QOL analyses suggested greater improvement with combined treatment than single treatment. A more complete population analysis demonstrated the efficacy of duloxetine with or without PFMT and suggested combined treatment was more effective than either treatment alone. CONCLUSIONS: The data support significant efficacy of combined PFMT and duloxetine in the treatment of women with SUI. We hypothesize that complementary modes of action of duloxetine and PFMT may result in an additive effect of combined treatment.
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RANDOMIZED CROSS-OVER COMPARISON OF ADHESIVELY-COUPLED COLOSTOMY POUCHING SYSTEMS Kirsten Berg, Kirsten.berg@sk-hwi.de, Triwalk
RATIONALE AND PURPOSE: Ostomy pouching systems affect users' well-being and quality of life, yet few controlled trials compare their effectiveness. Innovative adhesively coupled systems have flexible low profiles allowing pouch removal/replacement without changing the skin barrier or wafer. This facilitates inspection or pouch changes without disrupting peri-stomal skin. OBJECTIVE: A prospective randomized open-label crossover study was conducted to compare clinical performance and patient preferences for two adhesively coupled pouching systems during normal use: a gelatin/pectin based skin barrier sealed to the pouch with Adhesive Coupling Technology (System E*) or a grooved base-plate wafer adhesive pouch coupling system (System F**). METHODOLOGY: Participants giving informed consent were randomly assigned to use one system for 5 skin barrier/wafer changes or up to 15 days, then used the alternative system for a similar period. Performance of the 2 ostomy systems was rated using standardized scales on diary cards during use. Participants rated each system after use and reported comparative preferences at the end of the study. OUTCOMES: Thirtynine participants used a total of 1645 pouches and 342 skin barriers experiencing similar safety for both systems and more adequate pouch wear times with System E (P < .01). End-phase ratings significantly favored System E on 10 of 17 attributes (P ≤ .04) and System F on none. More participants preferred System E on all 7 study-end measures, 5 significantly: comfort, flexibility, wear time, ease of removal, and overall performance (P < .02). CONCLUSIONS: These participant-reported ostomyrelated outcomes support evaluation and selection of products to enhance ostomy patients' well-being and quality of life. PRODUCT NOTATIONS: *Esteem synergy ostomy system, ConvaTec, Princeton, NJ, USA. Esteem synergy is a registered trademark of E. R. Squibb & Sons, L.L.C. **Assura AC ostomy system, also called EasiFlex in some countries, both registered trademarks of Coloplast Corporation. Toshiko Kaitani, MSN, RN, CWOCN, Kaitani@Myu.Ac.Jp, and Keiko Tokunaga, BSN, RN, ET, Miyagi University School of Nursing, Miyagi, PURPOSE: Various studies have reported on patients who develop pressure ulcers within the first week or fortnight of hospitalization in the critical care setting. The purpose of this study was to identify pressure ulcer risk indicators and when the pressure ulcer occur in the critical care setting. METHODOLOGY: A prospective longitudinal study was designed to collect relevant data on all patients at risk of developing pressure ulcers. The study facility is a 606-bed tertiary care hospital. One-hundred six of the 272 subjects admitted to the ICU/HCU during 3-month period were included in this study. The criteria for selection were being: (1) an adult older than 19 years of age, (2) free from pressure ulcers on admission, and (3) hospitalized more than 24 hours. The data were collected on admission to the ICU/HCU at 48 and 72 hours after admission, and then every 48 hours until discharge, or for a maximum of 15 days. The Pearson, Chi-square, and logistic-regression analyses were used to identify the variables associated independently with pressure ulcers (SPSS ver.11.0). Informed consent was obtained. RESULTS: Subjects' mean age was 60.0, SD 15.8 years, and mean APACHE2 score was 7.8, SD 4.3. Nineteen (7.5%) of the 272 subjects developed pressure ulcers during the study, and 8 (42.1%) of the 19 subjects developed them during surgery, which was statistically significant. (P < .004) The incidence of pressure ulcers in surgical patients in this study was 7.1%, and multivariate analysis revealed that undergoing lengthy surgical procedures, being an emergency postoperative patients, using lateral and prone position, and body mass index (BMI) were key factors. Receiver-operating characteristic (ROC) curves for BMI show best balance between sensitivity and specificity at 20.37 (75.0%, 78.1%). CONCLUSION: In the critical care setting, it is important to prevent pressure ulcer formation during surgery. Additionally, being emergency postoperative patients, lateral position, prone position, and a BMI below 20.37 were significant risk factors for pressure ulcer formation. Donald Hendrickson, PhD, drh@hml.com; Katie Bilger; Keri Nixon; and David Brett, BS, MS, HML, Muncie, Ind PURPOSE: To assess the antimicrobial activity of burn wound dressings. RATIONALE: As new and innovative burn wound dressings are introduced to the public it becomes important to determine their antimicrobial activity and compare them with preexisting treatments. In this study the antimicrobial properties of several silver coated dressings were examined in vitro with the log reduction test method. METHODOLOGY: Silver-coated dressings and solutions of antibiotic resistant Pseudomonas aeruginosa (PA), methicillin-resistant Staphylococcus aureus (MRSA), and vancomycin-resistant Enterococcus faecium (VRE) were added to absorbent material. After incubation for 30 minutes at 37°C, the samples were vortexed. Bacterial survival numbers were obtained by a standard plate count procedure using Mueller Hinton Agar. The log reduction was calculated. RESULTS: The nanocrystalline silver-coated dressing produced a 6.5 log reduction of PA, a 6.24 log reduction of MRSA, and a 5.50 log reduction of VRE. The AgCMC/AgCl-and SSD-coated dressings produced a 4 log reduction for PA only. The metallic silver dressing resulted in a near 4 log reduction for PA. The AgCl and Ag/Carbon dressing did not have a reduction for any of the bacteria tested. The AgCMC/AgCl, Ag/PO4 and AG/NH4 dressings did not have a reduction for MRSA and VRE. The metallic silver dressing did not have much of a reduction for MRSA. A 2-hour incubation for the AgCMC/AgCl and Ag/NH4 did not increase the destruction PA, MRSA or VRE. CONCLUSIONS: This study demonstrated that nanocrystalline silver-coated dressing exhibited greater antimicrobial activity than any of the other silver coated topical wound care dressings studied. These results are in agreement with previous studies that included clinically significant antibiotic resistant bacteria. Although AgCMC/AgCl and SSD produced a 4 log reduction of PA, they did not give a 4 log reduction of MRSA or VRE.
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PATIENT RISK FACTORS FOR PRESSURE ULCERS IN THE CRITICAL CARE SETTING
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ASSESSMENT OF ANTIMICROBIAL ACTIVITY OF BURN WOUND DRESSINGS
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A COMPARISON OF WOUND ASSESSMENTS BY WOUND OSTOMY CONTINENT AND HOME CARE NURSES USING DIGITAL IMAGES Kathleen M. Buckley, PhD, RN, buckleyk@cua.edu; Binh Q. Tran, PhD; and Linda Koch Adelson, BSN, RN, CWOCN, Catholic University of America School of Nursing, Washington, DC PURPOSE: Home care nurses must be able to accurately assess a variety of wound types in order to make decisions about the appropriate wound care. In order to provide suitable educational programs and improve home care nurses' skills in assessing and using advanced wound care products and treatments, periodic evaluations of their knowledge base is necessary. The purpose of this study was to evaluate expert wound ostomy continence (WOC) and home care nurses' knowledge of wound assessment using digital images and case studies of patients with wounds. METHODOLOGY: Home care nurses were given a packet containing 10 brief case studies of various wounds with accompanying black-and-white images. In addition, they were able to view color digital images of the wounds, displayed by means of a PowerPoint presentation using an LCD projector. The nurses were asked to use checklists in assessing the stage of the wound, color and type of wound bed tissue, color and characteristics of the periwound, and presence of tunneling and undermining. Findings were compared to those based on the expertise of a group of WOC nurses. STATISTICS: Mean frequencies of percent agreement among and between the home care and WOC nurses for the presence or absence of each wound characteristic were determined. RESULTS: There appear to be clear limitations of using digital images for wound assessments in home care. Aside from nurses not being able to use their sense of touch or smell, there was considerable variability even among the wound experts in agreement on color, presence of wound bed tissue types and periwound characteristics. CONCLUSION: The researchers identified some of the challenges of using digital image technology, and have offered suggestions that may improve the quality of wound photography and streamline and validate wound assessment in the process.
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COMPARATIVE STUDY OF THE USE OF ANTIMICROBIAL BARRIER FILM DRESSING IN POSTOPERATIVE INCISION CARE
Joyce Pittman, MSN, NP, CWOCN, jpittman@schneckmed.org; Judy Tape, BSN, RN, CIC; John Pelliccia, MD; and Dorothy Tanner, MSN, NP, Schneck Medical Center, Seymour healthcare setting affect more than 2 million Americans per year. One of the major healthcare initiatives is to decrease the rate of surgical site infections. It is to this purpose that our study was undertaken. METHODOLOGY: This was a quasi-experimental study with before/after design. Convenience sampling of patients that had pain implemented device surgery was obtained from 1999-2003 prior to intervention implementation and those patients in 2004 postintervention implementation. Retrospective record review was conducted on patients prior to intervention being implemented and post-intervention implementation. Review utilized CDC guideline and definition for surgical site infection to identify surgical site infection. STATISTICS: The data were analyzed using descriptive statistics and Chi-square. The before-intervention group was compared to the after-intervention group. RESULTS: Sixty-four patients participated in this study. In the before-intervention group, 16% surgical site infection rate was identified. In the afterintervention group, 9% surgical site infection rate was identified. CONCLUSION: The findings suggest that the use of antimicrobial barrier film dressing can reduce the rate of surgical site infections when used for postoperative pain implanted devices surgical sites. Keith F Cutting, MN, RN, Cert., Ed., kcutti01@fast24.co.uk; Richard J. White, PhD; and Paul Mahoney, MSc, Buckinghamshire University College, Chalfont St Giles The occurrence of wound infection remains an all-too-frequent global problem. Inappropriate clinical management of infected wounds is responsible for significant delays in healing and is a major cause of patient morbidity. Consensus on the best clinical management of wound infection has been hampered by the different needs and practices of a wide range of disciplines. Currently, there is significant unmet clinical need for a global consensus on the diagnosis and treatment of infected wounds. A step has been taken toward addressing this by the application of a Delphi approach to developing consensus on identifying wound infection. Delphi panels are a widely recognized method used to monitor and develop agreement in opinion across a range of disciplines and regional cultures. Such a tool has been recently applied in acquiring a consensus identifying the clinical criteria for wound infection in a variety of wound types. It is hoped that the consensus opinion gathered in this way will raise awareness of the subtle variations in the manifestation of wound infection and that this in turn will enhance clinical management of infected wounds. An international multidisciplinary panel (54 panel members) has been established consisting of wound specialists who are collectively involved with a variety of wounds. These wounds include arterial ulcers, diabetic foot ulcers, venous leg ulcers, pressure ulcers, and deep and partial-thickness burns, as well acute/surgical wounds. Data gathering has already been completed at a distance via a series of "rounds" where data is received, collated, and modified following expression of individual opinion. The results indicate that although there is some commonality of criteria between wound types subtle and sometimes distinct differences clearly exist. Empirical testing is now required followed by a controlled trial.
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DEVELOPING CLINICAL CRITERIA FOR WOUND INFECTION-A DELPHI APPROACH
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WHAT IS PRESSURE MAPPING TELLING ME? Laurie M. Rappl, PT, CWS, lrappl@spanamerica.com, Span-America, Greenville, SC Many people mistakenly believe that pressure mapping, also known as interface pressure mapping (IPM), is a way to predict the effectiveness of a support surface for all body types compared to other support surfaces. This is simply not true. There is no evidence that has ever linked IPMs to skin breakdown. IPMs are not the same is capillary closing pressure, as the subdermal pressures are 3-5 times higher than interface pressures. Comparison of products using IPMs is only viable if the same subject, the same mapping device, the same reading scale, the same bed frame, and the same subject clothing and position are all consistent. Different physical builds and body types will map differently on the same support surface. This presentation will pictorially show sideby-side IPM's to illustrate the differences between IPMs when different subjects are mapped, when different mapping devices are used, when different positions are used, when different bed frames are used. The reader will gain an appreciation for how little value there is in a single IPM picture and how difficult it is to use IPMs to predict support surface effectiveness. IPMs can be used as one piece of information in assisting in support surface choice for an individual patient but not for approximating surface effectiveness across a large population. Catherine A. Eager, BSN, RN, CET, CWS, woundcareprotocols@earthlink.net; Wolfgang Vanscheidt, MD; and R. Gary Sibbald, MD, Wound Care Protocols, Oregon City, Ore PURPOSE/RATIONALE: Venous ulcers require dressings that manage exudate and protect delicate peri-ulcer skin in addition to providing a moist environment that supports healing. A prospective randomized study compared effects of a 3-layer foam composite (V)* dressing, or a foam (F)** dressing in managing venous leg ulcers. METHODOLOGY: One-hundred seven patients randomized to the V (n = 55) or F (n = 52) protocols were managed until healing or up to 8 weeks in 15 US, Canadian, French, German, and UK centers. Dressing performance was assessed during dressing changes and at final evaluation. All products were used according to package insert instructions. Results were deemed statistically significant if P < .05. RESULTS: The V regimen healed or markedly improved surrounding skin in 54% of patients compared with 36% of F patients (P = .03). More V patients expressed "very good to excellent satisfaction" with conformability (87% of V patients and 75% of F patients; P = .05), with the dressing being nonsensitizing (72.8% and 52% respectively; P = .02), and with ease of dressing application (92.7% and 80.8%, respectively: P = .01). Comparable healing was experienced by both groups of patients. CONCLUSION: The findings reported in this study suggest that protocols of care including V foam composite dressings offer significant benefits beyond those of moist wound healing, protecting patients' delicate peri-ulcer skin with a highly conforming method of exudate management that is easy to apply. PRODUCT NOTATIONS: *Versiva, ConvaTec, a Bristol-Myers Squibb company; Versiva is a registered trademark of E. R. Squibb & Sons, L.L.C. **Allevyn Adhesive Hydrocellular dressing, T. J. Smith & Nephew Limited, Hull, UK.
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RANDOMIZED CONTROLLED STUDY: EFFECTS OF A THREE-LAYER FOAM COMPOSITE DRESSING COMPARED WITH A FOAM DRESSING IN MANAGING VENOUS LEG ULCERS
J WOCN ■ Volume 32/Number 3S Abstracts S27 ical, humanistic, and economic burdens of topical PU care were explored in real-world settings. METHODOLOGY: Outcomes from March 2001-December 2002, were analyzed for all 821 Stage II-IV PU on 295 patients in 1 long-term care (LTC) facility, 1 long-term acute care (LTAC) hospital, and 5 home care (HC) agencies. Staff selected wounds to receive care using standardized softwaregenerated validated wound care protocols, including pressure relief, guided by reliable and valid wound assessments. Wound specialists accessed protocols via telemedicine in home care, paper forms in LTC, or a desktop computer in the LTAC hospital. Protocols avoided gauze dressings, unless overruled by staff. RESULTS: Patients with full-thickness (FT) PU healed in 55 days (mean); partial-thickness (PT) PU, in 27 days (mean; P < .0001), suggesting greater costs to heal FT PU. Controlling for PU depth, baseline wound area and approximately 20% contraction during the first 14 days of care predicted healing. Controlling for depth of 331 PU with dressings recorded, faster mean healing time was associated with predominant use of fiber or hydrocolloid primary dressings vs gauze (P < .02). Infections (in 20% of PU) predicted delayed healing (P = .0009) though pain scores > 0 reported by 40% of patients did not. CONCLUSION: PU increase the clinical, humanistic and economic burden of real-world patient care, with FT PU further increasing these burdens. Healing outcomes using protocols of care including fiber or hydrocolloid dressings surpassed those using gauze-based protocols of care. DISCLOSURE: This research was supported by a grant from ConvaTec, a Bristol-Myers Squibb company. Sarah J. Gregory, BSc, (Hons), sgregor2@medgb.jnj.com; James Boyle, BSc, (Hons); Tracy J. Rennison, BSc, (Hons); and Breda M. Cullen, PhD, Johnson and Johnson Wound Management, North Yorkshire Previous studies have reported biochemical differences between acute and chronic wounds; these include differences in protease levels. Nonhealing wounds present with high levels of destructive proteases, resulting in a hostile environment in which important healing factors, such as growth factors, are readily degraded. These biochemical imbalances are thought to impact healing and may result for a number of different reasons. One important factor, which may initiate these biochemical changes, and known to delay wound healing, is wound infection. However, bacteria have been shown to populate many chronic wounds, which progress to healing. These observations suggest a balance is required between host response and bacterial action. Wound dressings that aim to control bioburden must therefore also address the biochemical imbalances. In this study we investigated the production of proteases by common wound pathogens and their effects on growth factors important to the healing process. We then investigated the in vitro antimicrobial effects of an ORC/collagen matrix containing silver-ORC*. This matrix was also incubated with proteases of both human and bacterial origin to investigate its action on destructive enzymes present in chronic wounds. Finally, ORC/collagen matrix containing silver-ORC* ability to preserve growth factors, from host and bacterial proteolytic degradation was tested. ORC/collagen matrix containing silver-ORC* has been shown to have antimicrobial properties against common chronic wound pathogens. It also absorbed harmful components like host serine and matrix metalloproteinases from chronic wound fluids, as well as proteolytic enzymes in bacterial supernatants. This matrix was capable of preserving important growth factors from proteolytic degradation in vitro. These results suggest ORC/collagen matrix may remove these noxious components, helping to restore a more normal wound-healing environment, even when bacterial populations are elevated. *ORC/ collagen matrix containing silver-ORC is PROMOGRAN PRISMA matrix, trademark of Johnson & Johnson Wound Management, a division of ETHICON, INC, NJ, USA. Sophie Bryant, joanne.taylor@healthworld.co.uk, ConvaTec Ltd, Flintshire RATIONALE: The application of modern technology has many benefits for clinical wound care, but wounds are increasingly managed in the community. Improving 'real-world' wound management, which can present a complex and varied clinical challenge and may carry a higher risk of infection, is therefore vital. This study investigated the effects of a moisture-retentive silvercontaining Hydrofiber wound dressing in patients with a variety of acute and chronic wounds treated under community conditions. METHODOLOGY: This international community-based product evaluation included 990 patients from 14 countries. No strict exclusion criteria were applied, and 48% of wounds showed evidence of infection at the initial assessment. The wounds evaluated were a mixture of diabetic foot ulcers, leg ulcers, pressure ulcers, burn wounds and postoperative wounds. All were dressed with the silver-containing Hydrofiber dressing for either 2 weeks (acute wounds) or 4 weeks (chronic wounds). Ease of dressing use, patient comfort and patient pain were assessed. Wound size and exudate management were also recorded. RESULTS: Eighty-five percent of wounds showed improvement following application of the silver-containing Hydrofiber dressing. The dressing had substantial benefits for quality of life, with 93% of patients rating overall comfort as 'good' or 'excellent.' Similarly, the dressing was rated 'good' or 'excellent' for ease of application and removal by 98% and 92% of clinicians, respectively. 58% of patients with chronic wounds reported an increase in the quality of periwound skin. Wound healing and comfort were also improved. CONCLU-SION: This silver-containing moisture-retentive Hydrofiber dressing offers several advantages for patients with wounds actively managed in the community. These include antimicrobial activity, improved wound healing, patient comfort and ease of use. Sarah J. Gregory, BSc, (Hons), sgregor2@medgb.jnj.com; Tracy J. Rennison, BSc, (Hons); and Breda M. Cullen, PhD, Johnson and Johnson Wound Management, North Yorkshire Hostile biochemical environments delay or prevent wound healing. Main contributors to this include prolonged inflammation caused by disease-related pathology, poor nutrition, and local infection. Treatment to achieve a biochemical balance may need to address levels of microorganism leading to infection. Historically, 2835-02_WJ3203-Abst-newrev.qxd 05/04/05 12:47 Page S27 S28 Abstracts J WOCN ■ May/June 2005 silver ions have been used as a topical antiseptic in wounds. There has been a resurgence recently driven by growing resistance to antibiotics. In wounds, with obvious infection, the cytotoxicity of silver is tolerated due to a greater need for bacterial balance. However, clinical signs of chronic wound infection may not be present, making it difficult to correctly determine diagnosis. In this study we investigated the effect of an ORC/collagen matrix containing silver-ORC* on human dermal fibroblasts and common antibiotic resistant, bacterial wound pathogens. Human dermal fibroblasts were incubated with extracts of silver dressings, prepared in serum free Dulbecco's Modified Eagle's Medium (DMEM). Cellular activity was assessed via a commercially available proliferation kit. Antimicrobial activity of the dressing was also investigated, using Log10 reduction. Clinically isolated vancomycin-resistant Enterococci (VRE) and methicillin-resistant Staphylococcus aureus (MRSA) were tested. Results show the ORC/collagen matrix contains enough ionic silver to effectively kill important wound pathogens while fibroblasts demonstrated an increased rate of metabolic activity. This appears to be a unique characteristic of this biomaterial. This in vitro work suggests silver concentrations in a collagen-ORC matrix do not harm important host cells but are cidal to wound pathogens and, appropriately used, may form a valuable addition to the options for managing non-healing wounds. ORC/collagen matrix containing silver-ORC is PROMO-GRAN PRISMA matrix, a trademark of Johnson & Johnson Wound Management, a division of ETHICON, INC, NJ, USA. Deborah Addison, BSc(Hons), CChem, MRSC, daddison@medgb.jnj. com; Tracy J. Rennison, BSc, (Hons); and Michelle Del Bono, Johnson & Johnson Wound Management, Gargrave PURPOSE/RATIONAL: An antimicrobial silver alginate dressing combining high absorbency and antimicrobial properties was evaluated in simulated tests to determine the silver ion release of the dressing over a number of days and the antimicrobial properties of the dressing. METHODOLOGY: Two test methods were used: (1) atomic absorption to determine silver ion release in simulated wound fluid, and (2) a log reduction test that exposes a small sample of dressing against a high bacterial loaded broth, measuring the log reduction of the bacteria over a specified time period. The dressing was placed and agitated in simulated wound fluid at 370C. Each day the sample was transferred to fresh wound fluid. At each 24-hour time point, the silver ion concentration in the simulated wound fluid was determined by atomic absorption. At the end of the extended test period, the same dressing sample was then placed in a log reduction test. RESULTS: The results shows that in simulated prolonged use conditions that the silver ion release for the product is sustained and consistent. The study is still in progression but close to completion. CONCLUSION: The antimicrobial alginate dressing in simulated in-use tests has demonstrated sustained and consistent silver ion release in simulated wound fluid over a specified time period. The log reduction in vitro microbiology testing that followed the simulated in-use test shows that the dressing is effective at reducing the number of viable bacteria within the broth. The antimicrobial alginate dressing has been shown to be effective in vitro against a wide range of human clinical isolates, including Pseudomonas aeruginosa, Escherichia coli, Streptococcus pyogenes, Staphylococcus aureus, Staphylococcus epidermidis, Klebsiella pneumoniae, and Candida albicans and also against resistant organisms MRSE, MRSA. Eric Flam, PhD, PE, ntlebnj@comcast.net, and Loretta I. Raab, RPh, NTL Associates, LLC, East Brunswick, NJ INTRODUCTION: When a bony prominence, such as the heel, is placed on a nondynamic support surface, there is an immediate reaction by the support surface and a peak pressure is registered at the interface between the bone and soft tissue. This interface is the origin site of many pressure ulcers. If the support surface under the heel can yield or deform, the pressure is reduced. A stable pressure is attained when deformation is completed. One of the primary assumptions regarding this type of pressure management is that the level of pressure reduction is related to the extent of this deformation. PURPOSE: The purpose of this study was to test this assumption by simultaneously measuring the pressure change and deformation. METHODOLOGY: To reflect the realworld situation, a test procedure employing a system with an instrumented model of a human body, with realistic skeleton and soft tissue, was developed and validated. Two groups of support surface materials were evaluated; polyurethane foams (control) and viscoelastic expanded urethanes (VE)*. RESULTS: The results indicated that both the reduction in pressure and amount of deformation were greater for the VE than for the control. These differences were statistically significant (<.05) at the sample size used. CONCLUSION: These findings support the conclusion that there is a significant relationship between pressure reduction and support surface deformation for the VE. DISCUSSION: The behavior of the VE is similar to a support surface that contains a thick fluid. The peak pressure occurs when the load is applied and the fluid does not have time to flow away from beneath the load. Shortly thereafter, the fluid does flow away, the support surface deforms, and the pressure drops. *Tempur, Tempur-Medical, Inc. Judith K. Harwood, BS, RN, CWOCN, judyh03@sbcglobal.net, Kaiser Bellflower Wound Center, Bellflower, Calif PURPOSE: Individuals confined to a hospital bed often experience a reduction of mobility that places them at risk for multiple system complications including pressure ulcer development. This project was developed to investigate the effect of the bed frame on tissue interface pressure. OBJECTIVE: A literature review indicates that multiple systems are effected by immobility such as cardiopulmonary, cardiovascular, musculoskeletal, gastrointestinal, and urinary systems. Also the integrementary system is affected and prolonged immobility is a major factor leading to the development of pressure ulcers. According to Mitchell et al (1998) , pressure, shear, and friction can be influenced by the bed frame. While there is surmountable technical and clinical evidence that support surfaces redistribute tissue interface pressure, only minimal evidence exists related to the effect of bed frames on pressure ulcer development. Therefore, a pressure map device was used to measure and describe the interface pressure on 5 different profiling bed frames in various care settings using the same pressure redistributing foam mattress replacement, same mapping device, and same human subject in the fowler position. OUTCOMES: The specific design of the 5 different types of electric profiling bed frames that were measured indicated the action of the frame effects the elements of pressure development: pressure, shear, and friction. CONCLUSION: The results of the findings will be reported during the oral or poster presentation. REFERENCES: Forrest SA. Research
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